<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Soc Mass Spectrom</journal-id><journal-id journal-id-type="iso-abbrev">J. Am. Soc. Mass Spectrom</journal-id><journal-id journal-id-type="publisher-id">js</journal-id><journal-id journal-id-type="coden">jamsef</journal-id><journal-title-group><journal-title>Journal of the American Society for Mass Spectrometry</journal-title></journal-title-group><issn pub-type="ppub">1044-0305</issn><issn pub-type="epub">1879-1123</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7496948</article-id><article-id pub-id-type="doi">10.1021/jasms.0c00238</article-id><article-categories><subj-group><subject>Account &#x00026; Perspective</subject></subj-group></article-categories><title-group><article-title>Mass Spectrometry Techniques in Emerging Pathogens Studies:
COVID-19 Perspectives</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Mahmud</surname><given-names>Iqbal</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath2"><name><surname>Garrett</surname><given-names>Timothy J.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department of Pathology, Immunology,
and Laboratory Medicine, <institution>University of
Florida</institution>, College of Medicine, Gainesville, Florida
32610, <country>United States</country></aff><aff id="aff2"><label>&#x02021;</label>Southeast Center for Integrated
Metabolomics (SECIM), Clinical and Translational Science Institute,
<institution>University of Florida</institution>, Gainesville,
Florida 32610, <country>United States</country></aff><aff id="aff3"><label>&#x000a7;</label>University of Florida Health,
<institution>University of Florida</institution>, Gainesville,
Florida 32610, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Tel: <email>(352)273-5050</email>. Email:
<email>tgarrett@ufl.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>09</month><year>2020</year></pub-date><elocation-id>jasms.0c00238</elocation-id><history><date date-type="received"><day>18</day><month>06</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>09</month><year>2020</year></date><date date-type="rev-recd"><day>02</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>Published by the American Chemical Society. All rights
reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Society for Mass
Spectrometry</copyright-holder><license license-type="open-access"><license-p>This article is made available via the PMC Open Access Subset for
unrestricted RESEARCH re-use and analyses in any form or by any
means with acknowledgement of the original source. These
permissions are granted for the duration of the World Health
Organization (WHO) declaration of COVID-19 as a global
pandemic.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js0c00238_0003" id="ab-tgr1"/></p><p>As corona virus disease 2019 (COVID-19) is a rapidly growing public
health crisis across the world, our knowledge of meaningful
diagnostic tests and treatment for severe acute respiratory
syndrome coronavirus 2 (SARS-COV-2) is still evolving. This
novel coronavirus disease COVID-19 can be diagnosed using
RT-PCR, but inadequate access to reagents, equipment, and a
nonspecific target has slowed disease detection and management.
Precision medicine, individualized patient care, requires
suitable diagnostics approaches to tackle the challenging
aspects of viral outbreaks where many tests are needed in a
rapid and deployable approach. Mass spectrometry (MS)-based
technologies such as proteomics, glycomics, lipidomics, and
metabolomics have been applied in disease outbreaks for
identification of infectious disease agents such as virus and
bacteria and the molecular phenomena associated with
pathogenesis. Matrix-assisted laser desorption ionization
time-of-flight mass spectrometry (MALDI-TOF/MS) is widely used
in clinical diagnostics in the United States and Europe for
bacterial pathogen identification. Paper spray ionization mass
spectrometry (PSI-MS), a rapid ambient MS technique, has
recently open a new opportunity for future clinical
investigation to diagnose pathogens. Ultra-high-pressure liquid
chromatography coupled high-resolution mass spectrometry
(UHPLC&#x02013;HRMS)-based metabolomics and lipidomics have been
employed in large-scale biomedical research to discriminate
infectious pathogens and uncover biomarkers associated with
pathogenesis. PCR-MS has emerged as a new technology with the
capability to directly identify known pathogens from the
clinical specimens and the potential to identify genetic
evidence of undiscovered pathogens. Moreover, miniaturized MS
offers possible applications with relatively fast, highly
sensitive, and potentially portable ways to analyze for viral
compounds. However, beneficial aspects of these rapidly growing
MS technologies in pandemics like COVID-19 outbreaks has been
limited. Hence, this perspective gives a brief of the existing
knowledge, current challenges, and opportunities for MS-based
techniques as a promising avenue in studying emerging pathogen
outbreaks such as COVID-19.</p></abstract><kwd-group><kwd>mass spectrometry</kwd><kwd>emerging pathogen</kwd><kwd>COVID-19</kwd><kwd>proteomics</kwd><kwd>glycomics</kwd><kwd>metabolomics and lipidomics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>js0c00238</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>js0c00238</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>The etiology of a novel type of coronavirus was identified on January 7, 2020,
in Wuhan City in the Hubei Province of China.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> This novel
coronavirus (CoV) was later named as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), and the disease it causes was called coronavirus
disease 2019 (COVID-19).<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Originally, the COVID-19
epidemic was concentrated in China, but it rapidly spread around the world
with approximately 15,547,081 known cases and 633,142 deaths as of July 23,
2020.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> COVID-19 is now one of the most devastating
pandemics that has affected public health on all six populated continents.
There are four known genera of CoV, alpha, beta, gamma, and delta that cause
a multitude of symptoms including severe respiratory issues, nervous system
alterations, immune dysfunction, as well as kidney, cardiovascular, lung,
and gastrointestinal malfunction.<sup><xref ref-type="bibr" rid="ref4">4</xref>&#x02212;<xref ref-type="bibr" rid="ref10">10</xref></sup>
According to recent studies, SARS-CoV-2 binds to the angiotensin converting
enzyme II (ACE2) receptors of the cell of nasal epithelia, lungs, or other
organs and triggers an immune response which is believed to ultimately lead
to symptoms.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> However, in many cases, individuals have no symptoms
that lead to COVID-19 but can still carry and transmit the virus for up to
14 days leading to profound exposure concerns.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref></sup> Several
research studies have suggested that COVID-19 is a silent spreader and can
be divided into asymptomatic where people carry the active virus but never
develop any symptoms, presymptomatic, where people have been infected and
are incubating the virus but do not show symptoms, and mildly symptomatic
where people feel slightly unwell from a COVID-19 infection but continue to
come in close contact with others.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> According to a recent
global health report, 1 in 5 people worldwide have an underlying health
condition that could increase their risk of severe COVID-19.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Several risk factors have been identified as associated
with COVID-19 and its disease severity, including older age, asthma,
underlying respiratory disorder,, hypertension, cardiac disease, renal
disease, diabetes, obesity, cancer, and smoking.<sup><xref ref-type="bibr" rid="ref17">17</xref>&#x02212;<xref ref-type="bibr" rid="ref20">20</xref></sup></p><p>Currently, there is no meaningful vaccine or treatment for this novel
coronavirus disease other than repurposed therapeutics that exhibit some
beneficial outcomes for severe illness.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> For example,
the use of dexamethasone resulted in lower mortality among those who were
receiving either invasive mechanical ventilation or oxygen alone but not
among those receiving no respiratory support.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> COVID-19
can be diagnosed using RT-PCR; however, due to inadequate access to reagents
and equipment, disease detection and management have been
slowed.<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> Precision medicine, individualized patient care,
requires suitable diagnostic approaches to tackle the challenging aspects of
virus outbreaks where many tests are needed in a rapid and deployable
approach.</p><p>According to the World Health Organization (WHO), outbreaks are inevitable and
often unpredictable events.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> The immediate priority for
COVID-19 diagnostic research is the development of oligonucleotide and
serological tests as well as detection with point-of-care devices.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> The long-term priority for studying outbreaks such as
COVID-19 is to integrate these existing techniques into multiomics
approaches to enable clinicians/researchers to better track healthy, sick,
and recovered patients.</p><p>Mass spectrometry (MS)-based integrated omics includes proteomics, glycomics,
metabolomics, and lipidomics studies which provide a comprehensive snapshot
of pathogen-induced changes to the host following infection, invasion,
persistence, and pathogenesis and can prime the identification of novel
therapeutic targets for preventing or lessening disease
severity.<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> Pathogen infection can be primed through the
manipulation of host metabolism.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Adaptation into the
host metabolic landscape is a prerequisite for viral pathogen to replicate,
thrive, and out-compete neighboring cells that they invade. Therefore,
understanding the role of metabolism through viral pathogenesis is valuable
for next generation therapy development. Here, we will provide current
integrated knowledge of MS-based genomics, proteomics, glycomics,
lipidomics, and metabolomics technologies in emerging pathogen studies,
specifically focused on the opportunities and challenges related to the
COVID-19 pandemic.</p></sec><sec id="sec1.1"><title>Mass Spectrometry-Based Proteomics in COVID-19</title><p>MS-based proteomic approaches such as liquid chromatography (LC)&#x02013;MS and
matrix-assisted laser desorption/ionization (MALDI)-MS have been
successfully utilized in clinical settings as diagnostic tools for
investigating viruses and their pathogenesis.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> Proteomics
approaches have been applied successfully in studying pandemics and
epidemics including dengue, chikungunya, zika, Ebola, swine flu, H1N1 and
other influenza, MERS-CoV, SARS, and SARS-CoV-2.<sup><xref ref-type="bibr" rid="ref32">32</xref>&#x02212;<xref ref-type="bibr" rid="ref37">37</xref></sup>
Endogenous proteins serve as receptors for the virus to enter host cells,
and thus, elucidation of the proteome has made attractive contributions to
antiviral therapies.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></p><p>As a pioneering study in COVID-19, using affinity purification mass
spectrometry, Gordon et al. identified 332 high-confidence
protein&#x02013;protein interactions between SARS-CoV-2 and human proteins
and suggested druggable targets to treat COVID-19.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup>
Using stable isotope labeled Tandem Mass Tag (TMT) MS-based proteomics, Shen
et al. identified dysregulation of multiple apolipoproteins including APOA1,
APOA2, APOH, APOL1, APOD, and APOM in patient&#x02019;s sera.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Using LC&#x02013;MS/MS-based proteomics of urine
specimens from COVID-19 patients, Li et al. found mild and severe COVID-19
patients with comorbidities were clearly differentiated from healthy
patients.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> This study identified that
intracellular cholesterol transporter 2 (NPC2), APOA1, and cubilin (CUBN)
were downregulated in severe COVID-19 patients, but cyclic AMP-responsive
element-binding protein 3, like protein 3 (CREB3L3), hypoxia up-regulated
protein 1 (HYOU1), heparin cofactor 2 (SERPIND1), and complement 3 (C3),
were upregulated in mild or severe COVID-19 patients. Using orbitrap
MS-based targeted proteomics, Bezstarosti et al. detected tryptic peptides
of SARS-CoV-2 proteins (NCAP, VME1) that could be utilized as a diagnostic
of COVID-19.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Moreover, proteomics using LC&#x02013;MS
for COVID-19 identified 27 proteins as signatures with disease severity
where 22 of them were upregulated, while the remaining 5 were downregulated
with increasing severity of COVID-19.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Over 6739
proteins were identified using LC&#x02013;MS-based global proteome analysis
of PBMCs from COVID-19 patients, and specifically, this study identified
that the nsp9 and nsp10 proteins from SARS-COV-2 interact with host NKRF, a
NF-kB repressor, and may precipitate the strong interleukin (IL)-8/IL-6
mediated chemotaxis of neutrophils and increased host inflammatory response
in COVID-19 patients.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> Using
nano-HPLC/nano-ESI-Orbitrap-MS/MS, Ihling et al. identified unique peptides
originating from SARS-CoV-2 nucleoprotein from a highly diluted gargle
solution of COVID-19 patients.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> A cancer cell model
system infected by SARS-CoV-2 followed by LC&#x02013;MS-based proteomics
revealed that diverse nucleic acid metabolism was critical for corona virus
replication and suggested an inhibitor of nucleotide pool biosynthesis as a
therapeutic for COVID-19 (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Using MALDI-MS combined multivariate
statistical analysis, Dattero et al. showed the potential of MALDI-MS as a
complementary diagnostic tool for discriminating SARS-CoV-2 from other
viruses.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Overall, LC and MALDI-MS based
proteomics has shown potential as a key COVID-19 research area; however,
development of rapid and sensitive MS techniques along with trials in larger
clinical studies are necessary to translate the beneficial aspects of
MS-based proteomics in pandemics like COVID-19 disease (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Summary of MS-Based Proteome, Lipidome, and Metabolome analyses
in COVID-19 Patients</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">proteomics in COVID-19
study</th><th style="border:none;" align="center">technique (sample)</th><th style="border:none;" align="center">sample preparation</th><th style="border:none;" align="center">sources</th></tr></thead><tbody><tr><td style="border:none;" align="left">Identified protein&#x02013;protein
interactions between SARS-CoV-2 and human
proteins</td><td style="border:none;" align="left">Affinity purification&#x000a0;LC&#x02013;MS (Vero
E6 and HEK 293T cells)</td><td style="border:none;" align="left">Samples were resuspended in 4% formic acid
and 2% acetonitrile solution and separated by a
reversed-phase gradient over a Nanoflow C18
column. Q-Exactive Plus mass spectrometer was used
for data acquisition.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref38">38</xref>)</td></tr><tr><td style="border:none;" align="left">Identified peptide sequence from SARS-CoV-2
nucleoprotein</td><td style="border:none;" align="left">Nano-HPLC/Nano-ESI-Orbitrap-MS/MS
(gargle&#x000a0;solution)</td><td style="border:none;" align="left">The protocol consists of an acetone
precipitation and tryptic digestion of proteins
contained within the gargle solution.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref44">44</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: APOA1, APOA2, APOH, APOL1,
APOD, and APOM</td><td style="border:none;" align="left">TMT MS (serum)</td><td style="border:none;" align="left">Ethanol used for virus inactivation, serum
was lysed using 50 &#x003bc;L of lysis buffer (8 M
urea in 100 mM 680 triethylammonium bicarbonate,
TEAB), reduced in 10 mM
tris(2-carboxyethyl)phosphine (TCEP), alkylated by
40 mM iodoacetamide (IAA) in darkness, dilution
done with 100 mM TEAB, and digestion with
double-step trypsinization.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref39">39</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: NPC2, APOA1, and CUBN</td><td rowspan="2" style="border:none;" align="left">LC&#x02013;MS/MS (urine)</td><td rowspan="2" style="border:none;" align="left">5 mM dithiotheitol (DTT) used
for virus inactivation. Urine samples were
alkylated with 10 mM iodoacetamide in darkness.
Proteins were digested with trypsin, and then the
digestion reaction was terminated by 1% formic
acid (FA) and the digested peptides were desalted
and dried before LC&#x02013;MS/MS analysis.</td><td rowspan="2" style="border:none;" align="left">(<xref ref-type="bibr" rid="ref40">40</xref>)</td></tr><tr><td style="border:none;" align="left">Upregulated: C3, CREB3L3, HYOU1, and
SERPIND1</td></tr><tr><td style="border:none;" align="left">Detected tryptic peptides of SARS-CoV-2
proteins (NCAP, VME1)</td><td style="border:none;" align="left">Orbitrap MS (Vero E6 cell)</td><td style="border:none;" align="left">Infected cells were boiled at 95 &#x000b0;C for
20 min to inactivate the virus. Cells were lysed
with cell lysis buffer, and proteins were reduced
and alkylated with DTT and IAA reagent,
respectively, and precipitated using
chloroform/methanol.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref41">41</xref>)</td></tr><tr><td style="border:none;" align="left">Upregulated: A1BG, ACTB, C1R, C1S, C8A, CD14,
CFB, CFH, CFI, CRP, FGA, FGB, FGG, HP, ITIH3,
ITIH4, LBP, LGALS3BP, LRG1, SAA1, SAA2, and
SERPINA10</td><td rowspan="2" style="border:none;" align="left">LC&#x02013;MS
(plasma/serum)</td><td rowspan="2" style="border:none;" align="left">8 M urea, 100 mM ammonium
bicarbonate (ABC), and 4.5 mM dithiothreitol (DTT)
were used for plasma/serum sample
denaturation/reduction. IAA was used for
alkylation, and digestion was carried out with
trypsin.</td><td rowspan="2" style="border:none;" align="left">(<xref ref-type="bibr" rid="ref42">42</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: ALB, APOA1, APOC1, TF, and
GSN</td></tr><tr><td style="border:none;" align="left">Identified nsp9 and nsp10 protein of
SARS-COV-2 interact with host NKRF</td><td style="border:none;" align="left">LC&#x02013;MS (patients&#x000a0;PBMC)</td><td style="border:none;" align="left">PBMC cells were lysed by urea buffer to
denature the proteins and sonicated twice on ice
to break the protein&#x02013;protein or
DNA&#x02013;protein interactions. TCEP (5 mM) and
iodoacetamide (10 mM) were used for reduction and
alkylation, respectively.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref43">43</xref>)</td></tr><tr><td style="border:none;" align="left">Spectral comparison and multivariate analysis
identified distinct cluster between SARS-CoV-2
detectable versus undetectable nasal
samples.</td><td style="border:none;" align="left">MALDI-TOF (nasopharyngeal swabs
samples)</td><td style="border:none;" align="left">1 &#x003bc;L of sample + 1 &#x003bc;L of HCCA
matrix (a solution containing
&#x003b1;-cyano-4-hydroxycinnamic acid diluted into
500 &#x003bc;L of acetonitrile, 250 &#x003bc;L of 10%
trifluoroacetic acid, and 250 &#x003bc;L of HPLC
grade water) for protein extraction.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref46">46</xref>)</td></tr><tr><td style="border:none;" align="left">Upregulated: Nucleotide metabolism
pool</td><td style="border:none;" align="left">LC&#x02013;MS (Caco-2&#x000a0;cell)</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref45">45</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">glycomics in COVID-19
study</th><th style="border:none;" align="center">technique (sample)</th><th style="border:none;" align="center">sample preparation</th><th style="border:none;" align="center">sources</th></tr></thead><tbody><tr><td style="border:none;" align="left">Identified N-, O-, N-and O-Glycosylation and
Fucosylation on hACE2</td><td style="border:none;" align="left">Ion-Trap MS (HEK&#x000a0;293&#x000a0;cell)</td><td style="border:none;" align="left">Purified hACE2 was expressed in HEK293 cells
in 50 mM ammonium bicarbonate solution. Sample
reduction, alkylation, and digestion were done by
25 mM DTT, 90 mM IAA, and trypsin,
respectively.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref49">49</xref>)</td></tr><tr><td style="border:none;" align="left">Identified glycan mimic polypeptide epitope
that modulate SARS-CoV-2 spike protein and host
ACE2 receptor interactions</td><td style="border:none;" align="left">LC&#x02013;MS
(HEK&#x000a0;293F&#x000a0;cell)</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref50">50</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">lipidomics in COVID-19
study</th><th style="border:none;" align="center">technique (sample)</th><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">sources</th></tr></thead><tbody><tr><td style="border:none;" align="left">Upregulated: Diglycerides (DGs), free fatty
acids (FAAs), and triglycerides (TGs)</td><td rowspan="2" style="border:none;" align="left">LC&#x02013;ESI&#x02013;MS/MS
(Plasma)</td><td rowspan="2" style="border:none;" align="left">50 &#x003bc;L of plasma/serum
homogenized with 1 mL solvent mixture (include
methanol, MTBE and internal standard mixture) for
lipid extraction.</td><td rowspan="2" style="border:none;" align="left">(<xref ref-type="bibr" rid="ref95">95</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: Phosphatidylcholines
(PCs)</td></tr><tr><td style="border:none;" align="left">Upregulated: Phosphotidycholine (PC) and
21-hydroxypregnenolone, the essential intermediate
for synthesizing corticosterone</td><td rowspan="2" style="border:none;" align="left">UPLC&#x02013;MS/MS (Sera)</td><td rowspan="2" style="border:none;" align="left">Serum samples were treated with
ethanol for viral deactivation. Ice-cold 100%
methanol was used for metabolite
extraction.</td><td rowspan="2" style="border:none;" align="left">(<xref ref-type="bibr" rid="ref39">39</xref>, <xref ref-type="bibr" rid="ref129">129</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: Glycerophospholipid and
sphingolipids</td></tr><tr><td style="border:none;" align="left">Upregulated: Hyperlipidemia</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref82">82</xref>)</td></tr></tbody></table><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">metabolomics in COVID-19
study</th><th style="border:none;" align="center">technique (sample)</th><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">sources</th></tr></thead><tbody><tr><td style="border:none;" align="left">Discriminated metabolites: TCA cycle,
carbamoyl phosphate of urea cycle, and guanosine
monophosphate (GMP) of nucleotide biosynthesis
pathways.</td><td style="border:none;" align="left">LC&#x02013;ESI&#x02013;MS/MS (Plasma)</td><td style="border:none;" align="left">3 volumes of ice-cold methanol were added to
1 volume of plasma/serum for protein precipitation
and metabolite extraction.</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref95">95</xref>)</td></tr><tr><td style="border:none;" align="left">Upregulated: kynurenine pathway with elevated
kynurenate, kynurenine, 8-methoxykynurenate in
COVID-19 patients.</td><td rowspan="2" style="border:none;" align="left">UPLC&#x02013;MS/MS&#x000a0;(Sera)</td><td rowspan="2" style="border:none;" align="left">Serum samples were treated with
ethanol for viral deactivation. Ice-cold 100%
methanol was used for metabolite solubilization
and extraction.</td><td rowspan="2" style="border:none;" align="left">(<xref ref-type="bibr" rid="ref39">39</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: choline and its derivative
phosphocholine as well as global suppression of
amino acids and derivatives such as glutamate,
arginine,
<italic>N</italic>-(<italic>I</italic>-arginino)succinate,
citrulline, ornithine, glutamine, 2-oxoglutarate,
<italic>N</italic>-acetyl-<sc>l</sc>-glutamate,
urea, fumarate, argininate, asymmetric
dimethylarginine, symmetric dimethylarginine,
homoarginine, and
<italic>N</italic>-acetylarginine</td></tr><tr><td style="border:none;" align="left">Upregulated: kynurenine, glucose, and free
fatty acids</td><td rowspan="2" style="border:none;" align="left">UHPLC&#x02013;MS (Sera)</td><td rowspan="2" style="border:none;" align="left">Sera were extracted via a
modified Folch method (chloroform/methanol/water
8:4:3). Twenty &#x003bc;L of serum was diluted in
130 &#x003bc;L of LC&#x02013;MS-grade water and then
600 &#x003bc;L of ice-cold chloroform/methanol (2:1)
mixture were used for metabolite
extraction.</td><td rowspan="2" style="border:none;" align="left">(<xref ref-type="bibr" rid="ref130">130</xref>)</td></tr><tr><td style="border:none;" align="left">Downregulated: Nitrogen metabolism including
creatine, creatinine, polyamine, and circulating
amino acids</td></tr><tr><td style="border:none;" align="left">Identified NAD dysregulation in COVID-19
patient&#x02019;s</td><td style="border:none;" align="left">LC&#x02013;MS/MS (A549&#x000a0;cell)</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref98">98</xref>)</td></tr></tbody></table></table-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p>MS-based proteomics to study COVID-19. Workflow developed based on
recent proteomic analysis on COVID-19 pandemic. SARS-CoV-2 virus
with different symptomatic patient conditions or infected cell
model are shown. Typically, serum, plasma, and PBMCs from blood
as well as urine, saliva, and nasal swabs have been utilized for
targeted or untargeted proteomic analysis in COVID-19 patients.
MS spectral comparison followed by multivariate statistical
analysis can be applied for biomarker analysis with different
levels of COVID-19 severities. For details about different
COVID-19 proteomic sample preparation, data collection, and
analysis, see <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js0c00238_0001" id="gr1" position="float"/></fig></sec><sec id="sec1.2"><title>Mass Spectrometry Based Glycomics in COVID-19</title><p>Glycomics analyzes the comprehensive study of glycomes, the entire complement
of sugars, whether free or present in other molecules. Glyocosylation is one
of the most common forms of post-translational modifications of proteins,
but glycan are also key players in lipid modification such as in
galactosylcerebrosides and phosphatidylinositols. In many cases, bacteria
and viruses utilize carbohydrate-carbohydrate interactions to infect the
host, and this phenomena could be pertinent to the ongoing COVID-19
pandemic.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Extensive glycosylation of virus spike
protein has been reported in MARS and SARS and offers a potential pathway to
study for treatment.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Indeed, heavy glycan occupancy
along with three novel O-glycosylation sites was observed in ACE2 receptor
infected by SARS-CoV-2.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> In another study, using
LC&#x02013;MS, SARS-CoV-2 infection showed glycans mimic the polypeptide
epitope that modulates Spike-ACE2 interactions.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> Based
on limited studies of glycans role in COVID-19, one can infer that glycans
are one of the key players not only in the viral envelope but also on host
receptor binding. Hence, understanding glycoscience in SARS-CoV-2 infection
is another meaningful window to guide current vaccine development policy for
COVID-19 pandemic.</p></sec><sec id="sec1.3"><title>Mass Spectrometry Based Lipidomics in COVID-19</title><p>MS-based lipidomics analyzes the targeted or global lipid profile (e.g., fatty
acids, glycerophospholipids, sphingolipids, glycerolipids, glycolipids, and
steroids) and its perturbation with disease or infection.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Lipidomics has had a tremendous impact in emerging pathogen studies.
Lipids play important roles at various stages of host&#x02013;pathogen
interactions and pathogenesis.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> For example, MS-based
lipidomics revealed that arbovirus which is transmitted by <italic>Aedes
aegypti</italic> mosquitoes leading to dengue, Zika, chikungunya, and
yellow fever, utilizes increased levels of glycerophospholipids,
sphingolipids, and fatty acids for viral replication.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> Studies based
on electron tomography identified that significant rearrangements of the
host cell membrane architecture occur upon infection.<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> As the host
cell membrane is enriched with lipid molecules, viral entry into the host
requires direct or indirect association or modulations of host membrane
lipids. Evidently, lipids play multifaceted roles in viral entry into the
host cell.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> Glycosphingolipids composed of a lipid and
carbohydrate moiety have been shown as receptors for members of the
nonenveloped viruses such as calicivirus (it includes genera of norovirus,
sapovirus, vesivirus, lagovirus, nebovirus, and recovirus), rotavirus,
polyomavirus, and parovirus families.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> The carbohydrate
moiety of host cell membrane glycosphingolipids helps to direct the
interaction between a host cell and the nonenveloped virus protein coat.
This interaction leads to the virus internalization and initiation of
infection.<sup><xref ref-type="bibr" rid="ref56">56</xref>&#x02212;<xref ref-type="bibr" rid="ref58">58</xref></sup> Lipid receptors such as LDLR (low density
lipoprotein receptor) act as an indirect receptor for hepatitis C virus
(HCV) and bovine viral diarrheal virus (BVDV) where these viruses initially
interact with LDL (low density lipoprotein) lipid in the bloodstream and
then the virus is transported to the proximity of the target cell that will
be infected via the association with the LDL&#x02013;LDLR complex and
eventually facilitates infection.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> In the case of
dengue, bis(monoacylglycero)phosphate (BMP) and phosphatidylserine (PS) act
as viral fusion cofactors for endosomal acidification-dependent fusion
machinery.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> After initial receptor interactions,
several viruses such as influenza, HIV, and Ebola use lipid microdomains,
known as membrane rafts and made by sphingolipids and cholesterol, as
cofactors for entry into the host cell, assembly, and
budding.<sup><xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref61">61</xref></sup></p><p>It has been shown that viruses use lipids as signaling molecules for
replication and infection. For example, phosphatidylinositol (PI) signaling
influences HCV and enterovirus replication,<sup><xref ref-type="bibr" rid="ref62">62</xref>,<xref ref-type="bibr" rid="ref63">63</xref></sup> cholesterol biosynthesis
stimulates Nile and dengue virus replication,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref></sup>
phosphatidylserine (PS) promotes Ebola virus
replication,<sup><xref ref-type="bibr" rid="ref66">66</xref>&#x02212;<xref ref-type="bibr" rid="ref68">68</xref></sup> and sphingomyelin (SM) and membrane lipid rafts are
involved in Ebola, Marburg, and influenza virus
infection,<sup><xref ref-type="bibr" rid="ref69">69</xref>&#x02212;<xref ref-type="bibr" rid="ref72">72</xref></sup>
while inhibiting <italic>de novo</italic> ceramide (Cer) synthesis
significantly decreased ceramide accumulation and enhanced influenza A/H1N1
replication.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></p><p>LC&#x02013;MS-based human blood plasma lipidome analysis identified that Ebola
infection promotes profound modulation in global lipid profiles where PS,
phosphatidylethanolamine (PE), Cer, phosphatidylglycerol (PG), and
diacylglycerol (DG) were shown as increased with fatalities and suggested
potential therapeutics toward targeting lipids such as PS in antiviral
therapy.<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> Ultra-High performance liquid
chromatography-electrospray ionization-quadrupole-time of flight-mass
spectrometry (UPLC-ESI-Q-TOF-MS)-based global lipidomics analysis of human
Huh-7 cells uninfected or infected with MERS-CoV or HCoV-229E demonstrated
that elevated levels of lysophosphatidylcholine (lysoPC), lysoPEs, and fatty
acids (FAs) assisted with the replication of HCoV-229E and MERS-CoV
viruses.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> As lipids play numerous indispensable
cellular functions and are involved in multiple steps in the virus life
cycle, a global understanding of the role lipids play in COVID-19 infection
could provide potentially significant insights about virus pathogenesis and
management. As a frontline study, using LC-ESI-MS/MS, Wu et al. identified
that DGs, FAs, and triglycerides (TGs) were identified in higher abundance
in the fatality group as well as increased with the deterioration of the
disease. In contrast, phosphatidylcholines (PC) were found as gradually
reduced lipids over the course of COVID-19 fatalities. Overall, this study
observed dyslipidemia in COVID-19 patients and provides evidence of
potential therapeutic strategies.<sup><xref ref-type="bibr" rid="ref76">76</xref></sup></p><p>In another study, using UPLC&#x02013;MS/MS, Shen et al. reported increased
levels of PCs and 21-hydroxypregnenolone, the essential intermediate for
synthesizing corticosterone, but decreased levels of glycerophospholipid and
notably downregulated sphingolipids in both nonsevere and severe COVID-10
patients.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup></p><p>As there is no specific vaccine/treatment available for COVID-19, knowledge
from lipidome studies can be useful to develop druggable targets. For
example, bioactive lipids such as oleoylethanolamide (OEA), arachidonic acid
(AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are known
from existing viral pathogenesis to inactivate enveloped viruses and inhibit
microbial proliferation/replication.<sup><xref ref-type="bibr" rid="ref77">77</xref>&#x02212;<xref ref-type="bibr" rid="ref79">79</xref></sup> As SARS-CoV-2, SARS, and MERS are
all enveloped viruses, AA, EPA, and DHA can be applied to inactivate these
virus infections and their appropriate doses may reduce morbidity and
mortality due to COVID-19 and other similar conditions.<sup><xref ref-type="bibr" rid="ref77">77</xref>&#x02212;<xref ref-type="bibr" rid="ref79">79</xref></sup></p><p>Pandemic influenza as well as the emergence of novel respiratory viruses
SARS-CoV, SARS-CoV-2, and MERS-CoV cause acute respiratory symptoms due to
the production of sputum, a lipid rich component, at the respiratory
tract.<sup><xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref81">81</xref></sup> It is evident from the discussion that bursts of
lipid accumulation are likely due to viral replication kinetics. In
contrast, a study identified development of hypolipidemia in patients with
COVID-19 symptoms where the degree of hypolipidemia positively correlated
with the disease severity.<sup><xref ref-type="bibr" rid="ref82">82</xref></sup> Overall, lipidomic studies
have shown several critical insights about the role of diverse lipid
molecules in COVID-19 pathogenesis. It will be a useful resource to
correlate lipid profiles with therapy or vaccine outcomes as well as
potential of drug targets to control the COVID-19 pandemic. Moreover, a
larger study of COVID-19 patients with different clinical conditions should
be subjected to global lipidome analysis to uncover the detailed role lipids
play in COVID-19 patients (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>MS-based metabolomics and lipidomics to study COVID-19. Recent
metabolomics and lipidomics study on COVID-19 pandemic was used
to develop this workflow. SARS-CoV-2 virus with different
symptomatic patient conditions or infected cell models are
shown. Typically, serum, plasma, and PBMCs from blood and other
biomatrices such as urine, saliva, swab, and breath specimens
can be utilized for targeted or untargeted metabolomics or
lipidomics analysis in COVID-19 patients. MS spectral comparison
followed by multivariate statistical analysis can be utilized to
study metabolite or lipid-based biomarker with different level
of COVID-19 severities. For detail about different COVID-19
metabolomic and lipidomic study sample preparation, data
collection, and analysis, see <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js0c00238_0002" id="gr2" position="float"/></fig></sec><sec id="sec1.4"><title>Mass Spectrometry Based Metabolomics in COVID-19</title><p>MS-based metabolomics studies targeted or untargeted metabolites (e.g.,
carbohydrates, amino acids, organic acids, amines, nucleotides, aliphatic,
and aromatic compounds) and their perturbation with disease or
infection.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref84">84</xref></sup> Metabolites are transformed
chemical entities during cellular metabolism and serve as direct signatures
of biochemical activity; therefore, their levels are exquisitely sensitive
to a wide range of perturbations linked to disease onset, infection, and/or
pathogenesis.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref86">86</xref></sup> MS-based
untargeted metabolomics is performed as a global analysis of metabolite
profiles in any given biological material and has the potential to uncover
thousands of metabolites and link them to their cellular
networks.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref87">87</xref></sup> Recently, MS-based untargeted metabolomics has been
utilized in discovery of metabolite-based biomarkers for the diagnostic of
many diseases with unmet challenges.<sup><xref ref-type="bibr" rid="ref88">88</xref>&#x02212;<xref ref-type="bibr" rid="ref92">92</xref></sup>
MS-based metabolomics has been applied in several pandemic and epidemic
diseases to identify potential therapeutic targets. For example,
LC&#x02013;HRMS-based metabolomics has been used to identify chemical ligands
that can block nucleoprotein, a promising antiviral druggable target of
Ebola and Marburg viruses.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> Using UHPLC&#x02013;Q-TOF MS
based global metabolomics, Tian et al. observed that H1N1 influenza virus
modulates energy metabolism including TCA cycle, lipid, nucleotide, and
glutathione metabolism to efficiently carry out its life cycle in the host
cell.<sup><xref ref-type="bibr" rid="ref94">94</xref></sup></p><p>In COVID-19 patients, using an LC-ESI-MS/MS-based targeted metabolomics
approach, Wu et al. reported malic acid of the TCA cycle, carbamoyl
phosphate of the urea cycle, and guanosine monophosphate (GMP) of nucleotide
biosynthesis were profoundly altered in COVID-19 fatal patients (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref95">95</xref></sup> In a
separate study, using UPLC&#x02013;MS/MS-based untargeted metabolomics, Shen
et al. performed molecular profiling of COVID-19 sera and identified
significant activation of the kynurenine pathway with elevated kynurenate,
kynurenine, and 8-methoxykynurenate in COVID-19 patients. In contrast,
another study found decreased levels of choline and its derivative
phosphocholine as well as global suppression of amino acids, and derivatives
such as glutamate, arginine,
<italic>N</italic>-(<italic>I</italic>-arginino)succinate, citrulline,
ornithine, glutamine, 2-oxoglutarate,
<italic>N</italic>-acetyl-<sc>l</sc>-glutamate, urea, fumarate, argininate,
asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine, and
<italic>N</italic>-acetylarginine were observed in the sera of
nonsevere COVID-19 patients compared to healthy (<xref rid="tbl1" ref-type="other">Table
<xref rid="tbl1" ref-type="other">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Similarly,
using both UHPLC&#x02013;MS-based targeted and untargeted metabolomics,
Thomas et al. identified increased levels of kynurenine, glucose, and free
fatty acids but widespread decreased levels of nitrogen metabolism including
creatine, creatinine, polyamine, and circulating amino acids in COVID-19
patients (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Viral
replication and host cell homeostasis both depend on the four nicotinamide
adenine dinucleotide (NAD) coenzymes, NAD+, NADH, NADP+, and NADPH, which
are the central catalysts of metabolism.<sup><xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref97">97</xref></sup> Using
LC&#x02013;MS/MS-based targeted metabolomics, Heer et al. identified
dysregulated NAD in SARS-CoV-2 infected cellular models.<sup><xref ref-type="bibr" rid="ref98">98</xref></sup> As MS-based metabolomics techniques allow us to measure many metabolites
relating to a wide variety of viral infection and pathogenesis, large-scale
comprehensive studies on COVID-19 can assist scientific research to better
understand this pandemic and potential treatments (<xref rid="fig2" ref-type="fig">Figure
<xref rid="fig2" ref-type="fig">2</xref></xref>).</p></sec><sec id="sec1.5"><title>Sample Preparation and Its Challenges in COVID-19 Study</title><p>Emerging pathogen sample types, sample processing, and development of their
specific extraction methods for MS-based technologies are challenging but
critically important. In COVID-19, saliva, nasopharyngeal swabs (NS), gargle
solution, sputum, bronchoalveolar lavage fluid (BLF), and exhaled breath
condensate (EBC) can be utilized for detection of SARS-CoV-2 particles. As
SARS-CoV-2 spreads via respiratory droplets, both BLF and EBC could be more
appropriate biospecimens for COVID-19 diagnosis.<sup><xref ref-type="bibr" rid="ref99">99</xref>&#x02212;<xref ref-type="bibr" rid="ref102">102</xref></sup>
Inparticular, EBC with or without COVID-19 patients could be promising for
SARS-CoV-2 detection. Saliva or NS or gargle solution sampling is
recommended for early diagnosis; in contrast, sputum or BLF sampling should
be used for detecting and monitoring COVID-19 as the lower respiratory tract
yields higher viral load with disease severity.<sup><xref ref-type="bibr" rid="ref102">102</xref></sup> Urine,
plasma, serum, and PBMCs from COVID-19 patients and diverse cellular models
with viral infection or drug treatment can be used to interpret the
molecular mechanism for diagnosis of COVID-19. During COVID-19 specimen
handling, an MS lab should follow proper PPE rules, processing of
inactivated virus or its containing specimens should be conducted in at
least BSL-2 cabinet, and samples should only be stored in a proper
designated freezer. Inactivation of SARS-CoV-2 or its containing materials
is a major challenge in emerging pathogen sample preparation. However,
different chemicals such as acetone, acetone/methanol, methanol/chloroform,
UV at 254 nm, heat treatment of 65 &#x000b0;C or greater, alkaline (pH &#x0003e; 12)
or acidic (pH &#x0003c; 3) conditions, or formalin can be used to inactivate
coronavirus in controlled laboratories at biosafety level 3 (BSL3).<sup><xref ref-type="bibr" rid="ref103">103</xref></sup> A multiomics sample preparation technique should be
explored for integrated omics analysis of COVID-19 (<xref rid="fig2" ref-type="fig">Figure
<xref rid="fig2" ref-type="fig">2</xref></xref>). Interestingly, MPLEx (metabolite,
protein, and lipid extraction) was developed for emerging pathogen including
SARS corona virus to partition a single sample into three distinct parts
(metabolites, proteins, and lipids) while simultaneously inactivating the
virus by solubilizing and disrupting the viral envelope and denaturing viral
proteins.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> Notably, COVID-19 MS coalition of MS
laboratories has been established and working since the beginning of this
pandemic to provide guidance and protocols on MS technologies-based sample
collection, processing, extraction, data collection, and analysis to reduce
the harm caused by the SARS-CoV-2 virus pandemic. As COVID-19 continues to
grow, MS-based multiomics methods should be developed to study disease
prognosis, assess biomarkers for diagnosis and treatment, understand the
impact of infective particles in the environment, and evaluate the response
of vaccine and therapeutics.</p></sec><sec id="sec1.6"><title>Future Perspectives</title><p>As a resource for MS-based COVID-19 research, this review explored the current
knowledge of SARS-CoV-2 infections and pathogenesis in context to genomics,
proteomics, glycomics, lipidomics, and metabolomics of diverse COVID-19
patient materials and cellular model systems. The rapid, sensitive, and
specific diagnosis of SARS-CoV-2 by fast and unambiguous testing is widely
needed in response to the current outbreak.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup>
LC&#x02013;MS-based technologies have been predominantly employed since the
beginning of the COVID-19 pandemic to identify SARS-CoV-2 using proteomic
markers, to understand drug targets, to evaluate drug efficacy, or to
elucidate the molecular mechanism upon SARS-CoV-2 pathogenesis and disease
severity. As COVID-19 continues to progress and the complexity of SARS-CoV-2
pathogenesis and symptoms continues to grow, the strength and beneficial
aspects of MS and its allied technologies should be utilized to better
understand the COVID-19 pandemic. One of biggest challenge in current
frontline PCR techniques for COVID-19 detection is its inability to detect
mutation and unknown pathogens. PCR-based diagnostic testing is
predominantly based on the identification of individual genetic targets. MS
techniques such as PCR-ESI-MS (polymerase chain reaction coupled to
electrospray ionization mass spectrometry) represents a novel multiplexed
method that has recently emerged for broad range pathogen testing.
PCR-ESI-MS technology is capable of identifying nearly all known pathogens
directly from clinical specimens as well as identifying genetic
evidence/amplicon of unknown pathogens with a broad genetic amplification
approach.<sup><xref ref-type="bibr" rid="ref104">104</xref></sup> Therefore, possibilities and
advantages of PCR-ESI-MS should be explored in COVID-19 diagnostics.</p><p>Rapid pathogen identification is a key aspect in an infectious disease outbreak
such as COVID-19 for appropriate preventative measures. However, current
COVID-19 diagnostic techniques such as PCR or immunoassay is insufficient
because of reagent shortages that can lead to a reduction in turnaround time
for disease detection. Recent developments of direct MS such as segmented
flow (SF)-MS and paper spray ionization (PSI)-MS have shown the potential
for rapid, sensitive, highly reproducible, and comparable results to
conventional LC&#x02013;MS in their ability to identify biomarkers in the
diagnosis of cancer and the discrimination of various bacterial strains,
respectively.<sup><xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref106">106</xref></sup> Notably, PSI-MS has emerged as a
rapid (&#x0003e;30 s) analytical technique to discriminate bacterial strains from
raw specimens with minimal to no sample preparation requirements; however,
the capability of PSI-MS in viral detection has not been studied. PSI-MS
should be explored as a method to differentiate different viral strains
based on potential strain specific molecular signatures.</p><p>In addition, MALDI-MS has been effective as a proteomics tool because of its
relatively high tolerance of mixtures and biological
contaminants.<sup><xref ref-type="bibr" rid="ref107">107</xref>,<xref ref-type="bibr" rid="ref108">108</xref></sup> MALDI-MS is a rapid analysis
technique developed between the 1980s and early 1990s, winning one fourth of
the Nobel Prize in 2002 for the analysis of proteins. Since its inception,
it has been employed for the analysis of DNA, proteins, peptides, lipids,
and small molecules.<sup><xref ref-type="bibr" rid="ref109">109</xref>&#x02212;<xref ref-type="bibr" rid="ref113">113</xref></sup>
MALDI has also been translated to clinical diagnostics for microorganism
identification of infections and is now widely used across the United States
and Europe in bacteria identification.<sup><xref ref-type="bibr" rid="ref114">114</xref></sup> Therefore, the
application of MALDI-MS into emerging pathogen research has the potential to
add value to current COVID-19 detection as well as utilize current equipment
present in many clinical laboratories.</p><p>However, many MS instruments are either high cost to obtain or require a
significant lab footprint to operate for many clinics. Hence, the
development or translational of portable MS can be very important for
clinical lab adoption as well as the potential for remote testing and
screening. Indeed, miniaturized MS has been around for a decade as a fast
and portable analytical tool in space research, security, and food science
but it often faces the challenge of false expectations.<sup><xref ref-type="bibr" rid="ref115">115</xref></sup> With improve performance and sensitivity, miniaturized MS can have many
potential applications including in disease outbreaks such as COVID-19.</p><p>It is likely that many different technologies will contribute to develop
strategies for treatment such as antiviral compounds, bioactive molecules,
purified plasma, monoclonal antibodies (mAbs), viral molecule analogous
compound, and vaccines to eventually prevent COVID-19. Besides MS
technologies, nuclear magnetic resonance (NMR) spectroscopy is also often
use as a rapid, quantitative, and highly reproducible approach in a variety
of systems biology research and could be applicable in disease
outbreaks.<sup><xref ref-type="bibr" rid="ref116">116</xref>&#x02212;<xref ref-type="bibr" rid="ref120">120</xref></sup>
However, MS-based technologies have incredible potential in this space. For
example, mAbs has shown a wide range of therapeutic benefit in
COVID-19.<sup><xref ref-type="bibr" rid="ref121">121</xref></sup> However, higher quality
characterization of intact mAbs is important. Top-down MS-based proteomics
isa comprehensive technique used to decipher intact protein structure with
significantly higher detection efficiency of protein level sequence and post
translational modifications (PTMs). Therefore, top-down MS can be utilized
for global elucidation of mAbs structure and PTMs by fragmentation.<sup><xref ref-type="bibr" rid="ref122">122</xref></sup> Top-down MS can be applied in COVID-19 for identifying
protein with immunogenic response as vaccine candidate.</p><p>Biomarkers associated with COVID-19 disease severity or treatment should be
actively explored through an MS-based multiplex approach. Downregulated
apolipoproteins and elevated nucleotide metabolism has been identified as a
molecular signature with COVID-19 disease severity and suggest that these
metabolic vulnerabilities can be further validated from a therapeutic
standpoint. Consistent with several other pandemic and epidemic diseases,
lipidomics of COVID-19 patients has shown association of lipid levels with
disease severity. The role of FAs, glycerolipid, glycerophospholipid, and
sterol lipids should be investigated with severe or mild COVID-19 patients.
Bioactive lipids have been implicated as antiviral agents. Hence,
therapeutic aspects of bioactive lipids such as OEA, AA, EPA, and DHA should
be further explored for treating COVID-19. Accumulation of ceramide has been
shown to negatively affect viral pathogenesis including influenza virus.
Therefore, the detailed role of ceramide and its potential therapeutic
benefit should be explored in COVID-19.</p><p>Similarly, in metabolomics, the kynurenine pathway has been implicated as a key
elevated metabolic dependency as well as suppression of amino acid pools in
COVID-19 patients. In addition, metabolomics has been utilized to predict
antiviral drug efficacy in COVID-19.<sup><xref ref-type="bibr" rid="ref123">123</xref></sup> Therefore, the
level of metabolites should be actively explored with immune response,
vaccine or drug efficacy. Diverse genetic or epigenetic factors have been
identified with viral infection and pathogenesis and could be explored to
better understand the host immune response and therapeutic
target.<sup><xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref125">125</xref></sup> Different post-translational modifications such as
glycosylation, ubiquitination, acetylation, methylation, and phosphorylation
have shown association with diverse pathogen infection, and their role
should also be investigated in context with SARS-CoV-2 infection and disease
progression in COVID-19.<sup><xref ref-type="bibr" rid="ref126">126</xref>,<xref ref-type="bibr" rid="ref127">127</xref></sup> Extracellular vehicles (EVs) such
as exosomes have been identified as a molecular vehicle that can carry host
and pathogen-derived nucleic acid, protein, metabolite, and lipid.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> Hence, the role of EVs in SARS-CoV-2 viral infection,
transmission, and pathogenesis should be explored in COVID-19.</p><p>Discovery of biomarkers and investigation of altered molecular networks through
an integrated &#x0201c;omics&#x0201d; approach could be a valuable tool for
better understanding of COVID-19. As proteomics, glycomics, lipidomics, and
metabolomics are end products of upstream genomic and transcriptomics
activities, future research should focus on integrated omics in COVID-19
which could help to better understand the molecular mechanisms of infection,
pathogenesis, and therapeutic targets. As antiviral strategies are broadly
based on directly targeting the virus or indirectly targeting the virus via
host molecular modulation, MS-based multiplexing technologies could open
critical knowledge in these fields for defeating the COVID-19 pandemic.</p><p>Overall, since the current testing capacity by conventional PCR based methods
is insufficient due of shortages of global supplies such as RNA extraction
kits and PCR reagents, alternative and/or complementary testing assays
should be developed. Here, we suggest that targeted and untargeted MS-based
multiplexing technologies could have potential to accelerate the
understanding of the complexity of COVID-19 pandemic and its management.</p></sec></body><back><notes notes-type="" id="notes1"><title>Author Contributions</title><p>I.M. conceptualized and wrote the manuscript. T.G. reviewed and edited the
manuscript before submission.</p></notes><notes notes-type="COI-statement" id="NOTES-d7e947-autogenerated"><p>The authors declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We apologize to authors whose work is not cited in the perspective due to page
limitation.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="weblink" id="cit1"><article-title>Coronavirus
disease 2019</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</uri>
(accessed 2020-05-10).</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Gorbalenya</surname><given-names>A. E.</given-names></name>; <name><surname>Baker</surname><given-names>S. C.</given-names></name>; <name><surname>Baric</surname><given-names>R. S.</given-names></name>; <name><surname>de Groot</surname><given-names>R. J.</given-names></name>; <name><surname>Drosten</surname><given-names>C.</given-names></name>; <name><surname>Gulyaeva</surname><given-names>A. A.</given-names></name>; <name><surname>Haagmans</surname><given-names>B. L.</given-names></name>; <name><surname>Lauber</surname><given-names>C.</given-names></name>; <name><surname>Leontovich</surname><given-names>A. M.</given-names></name>; <name><surname>Neuman</surname><given-names>B. W.</given-names></name>; <name><surname>Penzar</surname><given-names>D.</given-names></name>; <name><surname>Perlman</surname><given-names>S.</given-names></name>; <name><surname>Poon</surname><given-names>L. L. M.</given-names></name>; <name><surname>Samborskiy</surname><given-names>D. V.</given-names></name>; <name><surname>Sidorov</surname><given-names>I. A.</given-names></name>; <name><surname>Sola</surname><given-names>I.</given-names></name>; <name><surname>Ziebuhr</surname><given-names>J.</given-names></name>
<article-title>Coronaviridae Study Group of the International
Committee on Taxonomy of Viruses. The Species Severe Acute
Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV
and Naming It SARS-CoV-2</article-title>. <source>Nat. Microbiol.</source>
<year>2020</year>, <volume>5</volume> (<issue>4</issue>), <fpage>536</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-020-0695-z</pub-id>.<pub-id pub-id-type="pmid">32123347</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="weblink" id="cit3"><article-title>Coronavirus
Update (Live): 4,168,677 Cases and 283,200 Deaths from COVID-19
Virus Pandemic - Worldometer</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.worldometers.info/coronavirus/">https://www.worldometers.info/coronavirus/</uri> (accessed
2020-05-10).</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Ong</surname><given-names>J.</given-names></name>; <name><surname>Young</surname><given-names>B. E.</given-names></name>; <name><surname>Ong</surname><given-names>S.</given-names></name>
<article-title>COVID-19 in Gastroenterology: A Clinical
Perspective</article-title>. <source>Gut</source>
<year>2020</year>, <volume>69</volume> (<issue>6</issue>), <fpage>1144</fpage>&#x02013;<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2020-321051</pub-id>.<pub-id pub-id-type="pmid">32198152</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Ng Kee Kwong</surname><given-names>K. C.</given-names></name>; <name><surname>Mehta</surname><given-names>P. R.</given-names></name>; <name><surname>Shukla</surname><given-names>G.</given-names></name>; <name><surname>Mehta</surname><given-names>A. R.</given-names></name>
<article-title>COVID-19, SARS and MERS: A Neurological
Perspective</article-title>. <source>J. Clin. Neurosci.</source>
<year>2020</year>, <volume>77</volume>, <fpage>13</fpage><pub-id pub-id-type="doi">10.1016/j.jocn.2020.04.124</pub-id>.<pub-id pub-id-type="pmid">32417124</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="book" id="cit6"><person-group person-group-type="allauthors"><name><surname>Yalameha</surname><given-names>B.</given-names></name>;
<name><surname>Roshan</surname><given-names>B.</given-names></name>;
<name><surname>Bhaskar</surname><given-names>L.
V.</given-names></name>;
<name><surname>Mohmoodnia</surname><given-names>L.</given-names></name></person-group><article-title>Perspectives on the Relationship of Renal Disease and
Coronavirus Disease 2019</article-title>. <year>2020</year>,
<volume>9</volume> ( (<issue>2</issue>), ),
<fpage>5</fpage>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Tay</surname><given-names>M. Z.</given-names></name>; <name><surname>Poh</surname><given-names>C. M.</given-names></name>; <name><surname>R&#x000e9;nia</surname><given-names>L.</given-names></name>; <name><surname>MacAry</surname><given-names>P. A.</given-names></name>; <name><surname>Ng</surname><given-names>L. F. P.</given-names></name>
<article-title>The Trinity of COVID-19: Immunity, Inflammation and
Intervention</article-title>. <source>Nat. Rev. Immunol.</source>
<year>2020</year>, <volume>20</volume>, <fpage>363</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-020-0311-8</pub-id>.<pub-id pub-id-type="pmid">32346093</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Gori</surname><given-names>T.</given-names></name>; <name><surname>Lelieveld</surname><given-names>J.</given-names></name>; <name><surname>M&#x000fc;nzel</surname><given-names>T.</given-names></name>
<article-title>Perspective: Cardiovascular Disease and the Covid-19
Pandemic</article-title>. <source>Basic Res. Cardiol.</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1007/s00395-020-0792-4</pub-id>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Lahiri</surname><given-names>D.</given-names></name>; <name><surname>Ardila</surname><given-names>A.</given-names></name>; <name><surname>D</surname><given-names>L.</given-names></name>; <name><surname>A</surname><given-names>A.</given-names></name>
<article-title>COVID-19 Pandemic: A Neurological
Perspective</article-title>. <source>Cureus J. Med. Sci.</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.7759/cureus.7889</pub-id>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Dietz</surname><given-names>W.</given-names></name>; <name><surname>Santos-Burgoa</surname><given-names>C.</given-names></name>
<article-title>Obesity and Its Implications for COVID-19
Mortality</article-title>. <source>Obesity</source>
<year>2020</year>, <volume>28</volume>, <fpage>1005</fpage><pub-id pub-id-type="doi">10.1002/oby.22818</pub-id>.<pub-id pub-id-type="pmid">32237206</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Zhou</surname><given-names>P.</given-names></name>; <name><surname>Yang</surname><given-names>X.-L.</given-names></name>; <name><surname>Wang</surname><given-names>X.-G.</given-names></name>; <name><surname>Hu</surname><given-names>B.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Si</surname><given-names>H.-R.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Huang</surname><given-names>C.-L.</given-names></name>; <name><surname>Chen</surname><given-names>H.-D.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Luo</surname><given-names>Y.</given-names></name>; <name><surname>Guo</surname><given-names>H.</given-names></name>; <name><surname>Jiang</surname><given-names>R.-D.</given-names></name>; <name><surname>Liu</surname><given-names>M.-Q.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Shen</surname><given-names>X.-R.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Zheng</surname><given-names>X.-S.</given-names></name>; <name><surname>Zhao</surname><given-names>K.</given-names></name>; <name><surname>Chen</surname><given-names>Q.-J.</given-names></name>; <name><surname>Deng</surname><given-names>F.</given-names></name>; <name><surname>Liu</surname><given-names>L.-L.</given-names></name>; <name><surname>Yan</surname><given-names>B.</given-names></name>; <name><surname>Zhan</surname><given-names>F.-X.</given-names></name>; <name><surname>Wang</surname><given-names>Y.-Y.</given-names></name>; <name><surname>Xiao</surname><given-names>G.-F.</given-names></name>; <name><surname>Shi</surname><given-names>Z.-L.</given-names></name>
<article-title>A Pneumonia Outbreak Associated with a New Coronavirus
of Probable Bat Origin</article-title>. <source>Nature</source>
<year>2020</year>, <volume>579</volume> (<issue>7798</issue>), <fpage>270</fpage>&#x02013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id>.<pub-id pub-id-type="pmid">32015507</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Sungnak</surname><given-names>W.</given-names></name>; <name><surname>Huang</surname><given-names>N.</given-names></name>; <name><surname>B&#x000e9;cavin</surname><given-names>C.</given-names></name>; <name><surname>Berg</surname><given-names>M.</given-names></name>; <name><surname>Queen</surname><given-names>R.</given-names></name>; <name><surname>Litvinukova</surname><given-names>M.</given-names></name>; <name><surname>Talavera-L&#x000f3;pez</surname><given-names>C.</given-names></name>; <name><surname>Maatz</surname><given-names>H.</given-names></name>; <name><surname>Reichart</surname><given-names>D.</given-names></name>; <name><surname>Sampaziotis</surname><given-names>F.</given-names></name>; <name><surname>Worlock</surname><given-names>K. B.</given-names></name>; <name><surname>Yoshida</surname><given-names>M.</given-names></name>; <name><surname>Barnes</surname><given-names>J. L.</given-names></name>
<article-title>SARS-CoV-2 Entry Factors Are Highly Expressed in Nasal
Epithelial Cells Together with Innate Immune
Genes</article-title>. <source>Nat. Med.</source>
<year>2020</year>, <volume>26</volume> (<issue>5</issue>), <fpage>681</fpage>&#x02013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-020-0868-6</pub-id>.<pub-id pub-id-type="pmid">32327758</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Pei</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>B.</given-names></name>; <name><surname>Song</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>T.</given-names></name>; <name><surname>Yang</surname><given-names>W.</given-names></name>; <name><surname>Shaman</surname><given-names>J.</given-names></name>
<article-title>Substantial Undocumented Infection Facilitates the
Rapid Dissemination of Novel Coronavirus
(SARS-CoV-2)</article-title>. <source>Science</source>
<year>2020</year>, <volume>368</volume> (<issue>6490</issue>), <fpage>489</fpage>&#x02013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb3221</pub-id>.<pub-id pub-id-type="pmid">32179701</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Lauer</surname><given-names>S. A.</given-names></name>; <name><surname>Grantz</surname><given-names>K. H.</given-names></name>; <name><surname>Bi</surname><given-names>Q.</given-names></name>; <name><surname>Jones</surname><given-names>F. K.</given-names></name>; <name><surname>Zheng</surname><given-names>Q.</given-names></name>; <name><surname>Meredith</surname><given-names>H. R.</given-names></name>; <name><surname>Azman</surname><given-names>A. S.</given-names></name>; <name><surname>Reich</surname><given-names>N. G.</given-names></name>; <name><surname>Lessler</surname><given-names>J.</given-names></name>
<article-title>The Incubation Period of Coronavirus Disease 2019
(COVID-19) From Publicly Reported Confirmed Cases: Estimation
and Application</article-title>. <source>Ann. Intern. Med.</source>
<year>2020</year>, <volume>172</volume> (<issue>9</issue>), <fpage>577</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.7326/M20-0504</pub-id>.<pub-id pub-id-type="pmid">32150748</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Hu</surname><given-names>Z.</given-names></name>; <name><surname>Song</surname><given-names>C.</given-names></name>; <name><surname>Xu</surname><given-names>C.</given-names></name>; <name><surname>Jin</surname><given-names>G.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name>; <name><surname>Ma</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>W.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Zheng</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Hu</surname><given-names>Z.</given-names></name>; <name><surname>Yi</surname><given-names>Y.</given-names></name>; <name><surname>Shen</surname><given-names>H.</given-names></name>
<article-title>Clinical Characteristics of 24 Asymptomatic Infections
with COVID-19 Screened among Close Contacts in Nanjing,
China</article-title>. <source>Sci. China: Life Sci.</source>
<year>2020</year>, <volume>63</volume> (<issue>5</issue>), <fpage>706</fpage>&#x02013;<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-020-1661-4</pub-id>.<pub-id pub-id-type="pmid">32146694</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Clark</surname><given-names>A.</given-names></name>; <name><surname>Jit</surname><given-names>M.</given-names></name>; <name><surname>Warren-Gash</surname><given-names>C.</given-names></name>; <name><surname>Guthrie</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>H. H. X.</given-names></name>; <name><surname>Mercer</surname><given-names>S. W.</given-names></name>; <name><surname>Sanderson</surname><given-names>C.</given-names></name>; <name><surname>McKee</surname><given-names>M.</given-names></name>; <name><surname>Troeger</surname><given-names>C.</given-names></name>; <name><surname>Ong</surname><given-names>K. L.</given-names></name>; <name><surname>Checchi</surname><given-names>F.</given-names></name>; <name><surname>Perel</surname><given-names>P.</given-names></name>; <name><surname>Joseph</surname><given-names>S.</given-names></name>; <name><surname>Gibbs</surname><given-names>H. P.</given-names></name>; <name><surname>Banerjee</surname><given-names>A.</given-names></name>; <name><surname>Eggo</surname><given-names>R. M.</given-names></name>; <name><surname>Nightingale</surname><given-names>E. S.</given-names></name>; <name><surname>O&#x02019;Reilly</surname><given-names>K.</given-names></name>; <name><surname>Jombart</surname><given-names>T.</given-names></name>; <name><surname>Edmunds</surname><given-names>W. J.</given-names></name>; <name><surname>Rosello</surname><given-names>A.</given-names></name>; <name><surname>Sun</surname><given-names>F. Y.</given-names></name>; <name><surname>Atkins</surname><given-names>K. E.</given-names></name>; <name><surname>Bosse</surname><given-names>N. I.</given-names></name>; <name><surname>Clifford</surname><given-names>S.</given-names></name>; <name><surname>Russell</surname><given-names>T. W.</given-names></name>; <name><surname>Deol</surname><given-names>A. K.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Procter</surname><given-names>S. R.</given-names></name>; <name><surname>Leclerc</surname><given-names>Q. J.</given-names></name>; <name><surname>Medley</surname><given-names>G.</given-names></name>; <name><surname>Knight</surname><given-names>G.</given-names></name>; <name><surname>Munday</surname><given-names>J. D.</given-names></name>; <name><surname>Kucharski</surname><given-names>A. J.</given-names></name>; <name><surname>Pearson</surname><given-names>C. A. B.</given-names></name>; <name><surname>Klepac</surname><given-names>P.</given-names></name>; <name><surname>Prem</surname><given-names>K.</given-names></name>; <name><surname>Houben</surname><given-names>R. M. G. J.</given-names></name>; <name><surname>Endo</surname><given-names>A.</given-names></name>; <name><surname>Flasche</surname><given-names>S.</given-names></name>; <name><surname>Davies</surname><given-names>N. G.</given-names></name>; <name><surname>Diamond</surname><given-names>C.</given-names></name>; <name><surname>van Zandvoort</surname><given-names>K.</given-names></name>; <name><surname>Funk</surname><given-names>S.</given-names></name>; <name><surname>Auzenbergs</surname><given-names>M.</given-names></name>; <name><surname>Rees</surname><given-names>E. M.</given-names></name>; <name><surname>Tully</surname><given-names>D. C.</given-names></name>; <name><surname>Emery</surname><given-names>J. C.</given-names></name>; <name><surname>Quilty</surname><given-names>B. J.</given-names></name>; <name><surname>Abbott</surname><given-names>S.</given-names></name>; <name><surname>Villabona-Arenas</surname><given-names>C. J.</given-names></name>; <name><surname>Hu&#x000e9;</surname><given-names>S.</given-names></name>; <name><surname>Hellewell</surname><given-names>J.</given-names></name>; <name><surname>Gimma</surname><given-names>A.</given-names></name>; <name><surname>Jarvis</surname><given-names>C. I.</given-names></name>
<article-title>Global, Regional, and National Estimates of the
Population at Increased Risk of Severe COVID-19 Due to
Underlying Health Conditions in 2020: A Modelling
Study</article-title>. <source>Lancet Glob. Health</source>
<year>2020</year>, <fpage>x</fpage><pub-id pub-id-type="doi">10.1016/S2214-109X(20)30264-3</pub-id>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Stefan</surname><given-names>N.</given-names></name>; <name><surname>Birkenfeld</surname><given-names>A. L.</given-names></name>; <name><surname>Schulze</surname><given-names>M. B.</given-names></name>; <name><surname>Ludwig</surname><given-names>D. S.</given-names></name>
<article-title>Obesity and Impaired Metabolic Health in Patients with
COVID-19</article-title>. <source>Nat. Rev. Endocrinol.</source>
<year>2020</year>, <volume>16</volume> (<issue>7</issue>), <fpage>341</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-020-0364-6</pub-id>.<pub-id pub-id-type="pmid">32327737</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Driggin</surname><given-names>E.</given-names></name>; <name><surname>Madhavan</surname><given-names>M. V.</given-names></name>; <name><surname>Bikdeli</surname><given-names>B.</given-names></name>; <name><surname>Chuich</surname><given-names>T.</given-names></name>; <name><surname>Laracy</surname><given-names>J.</given-names></name>; <name><surname>Biondi-Zoccai</surname><given-names>G.</given-names></name>; <name><surname>Brown</surname><given-names>T. S.</given-names></name>; <name><surname>Der Nigoghossian</surname><given-names>C.</given-names></name>; <name><surname>Zidar</surname><given-names>D. A.</given-names></name>; <name><surname>Haythe</surname><given-names>J.</given-names></name>; <name><surname>Brodie</surname><given-names>D.</given-names></name>; <name><surname>Beckman</surname><given-names>J. A.</given-names></name>; <name><surname>Kirtane</surname><given-names>A. J.</given-names></name>; <name><surname>Stone</surname><given-names>G. W.</given-names></name>; <name><surname>Krumholz</surname><given-names>H. M.</given-names></name>; <name><surname>Parikh</surname><given-names>S. A.</given-names></name>
<article-title>Cardiovascular Considerations for Patients, Health Care
Workers, and Health Systems During the COVID-19
Pandemic</article-title>. <source>J. Am. Coll. Cardiol.</source>
<year>2020</year>, <volume>75</volume> (<issue>18</issue>), <fpage>2352</fpage>&#x02013;<lpage>2371</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2020.03.031</pub-id>.<pub-id pub-id-type="pmid">32201335</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Yang</surname><given-names>J.</given-names></name>; <name><surname>Zheng</surname><given-names>Y.</given-names></name>; <name><surname>Gou</surname><given-names>X.</given-names></name>; <name><surname>Pu</surname><given-names>K.</given-names></name>; <name><surname>Chen</surname><given-names>Z.</given-names></name>; <name><surname>Guo</surname><given-names>Q.</given-names></name>; <name><surname>Ji</surname><given-names>R.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>
<article-title>Prevalence of Comorbidities and Its Effects in Patients
Infected with SARS-CoV-2: A Systematic Review and
Meta-Analysis</article-title>. <source>Int. J. Infect. Dis.</source>
<year>2020</year>, <volume>94</volume>, <fpage>91</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.017</pub-id>.<pub-id pub-id-type="pmid">32173574</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Ci&#x00105;&#x0017c;y&#x00144;ska</surname><given-names>M.</given-names></name>; <name><surname>Pabianek</surname><given-names>M.</given-names></name>; <name><surname>Szczepaniak</surname><given-names>K.</given-names></name>; <name><surname>U&#x00142;a&#x00144;ska</surname><given-names>M.</given-names></name>; <name><surname>Skibi&#x00144;ska</surname><given-names>M.</given-names></name>; <name><surname>Owczarek</surname><given-names>W.</given-names></name>; <name><surname>Narbutt</surname><given-names>J.</given-names></name>; <name><surname>Lesiak</surname><given-names>A.</given-names></name>
<article-title>Quality of Life of Cancer Patients during Coronavirus
Disease (COVID-19) Pandemic</article-title>. <source>Psychooncology.</source>
<year>2020</year>, <fpage>x</fpage><pub-id pub-id-type="doi">10.1002/pon.5434</pub-id>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Ison</surname><given-names>M. G.</given-names></name>; <name><surname>Wolfe</surname><given-names>C.</given-names></name>; <name><surname>Boucher</surname><given-names>H. W.</given-names></name>
<article-title>Emergency Use Authorization of Remdesivir: The Need for
a Transparent Distribution Process</article-title>. <source>JAMA</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1001/jama.2020.8863</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><article-title>Dexamethasone in
Hospitalized Patients with Covid-19 &#x02014; Preliminary
Report</article-title>. <source>N. Engl. J. Med.</source><year>2020</year>. DOI: <pub-id pub-id-type="doi">10.1056/NEJMoa2021436</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Udugama</surname><given-names>B.</given-names></name>; <name><surname>Kadhiresan</surname><given-names>P.</given-names></name>; <name><surname>Kozlowski</surname><given-names>H. N.</given-names></name>; <name><surname>Malekjahani</surname><given-names>A.</given-names></name>; <name><surname>Osborne</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>V. Y. C.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Mubareka</surname><given-names>S.</given-names></name>; <name><surname>Gubbay</surname><given-names>J. B.</given-names></name>; <name><surname>Chan</surname><given-names>W. C. W.</given-names></name>
<article-title>Diagnosing COVID-19: The Disease and Tools for
Detection</article-title>. <source>ACS Nano</source>
<year>2020</year>, <volume>14</volume>, <fpage>3822</fpage><pub-id pub-id-type="doi">10.1021/acsnano.0c02624</pub-id>.<pub-id pub-id-type="pmid">32223179</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Sethuraman</surname><given-names>N.</given-names></name>; <name><surname>Jeremiah</surname><given-names>S. S.</given-names></name>; <name><surname>Ryo</surname><given-names>A.</given-names></name>
<article-title>Interpreting Diagnostic Tests for
SARS-CoV-2</article-title>. <source>JAMA</source>
<year>2020</year>, <volume>323</volume>, <fpage>2249</fpage><pub-id pub-id-type="doi">10.1001/jama.2020.8259</pub-id>.<pub-id pub-id-type="pmid">32374370</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="weblink" id="cit25"><person-group person-group-type="allauthors"><collab>WHO</collab></person-group>. <article-title>Outbreak
Communication Guidelines</article-title><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications-detail/who-outbreak-communication-guidelines">https://www.who.int/publications-detail/who-outbreak-communication-guidelines</uri>
(accessed 2020-05-12).</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="weblink" id="cit26"><article-title>Report of the
WHO-China Joint Mission on Coronavirus Disease 2019
(COVID-19)</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)">https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)</uri>
(accessed 2020-05-20).</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="book" id="cit27"><person-group person-group-type="allauthors"><name><surname>Nicora</surname><given-names>C. D.</given-names></name>;
<name><surname>Sims</surname><given-names>A.
C.</given-names></name>;
<name><surname>Bloodsworth</surname><given-names>K.
J.</given-names></name>; <name><surname>Kim</surname><given-names>Y.-M.</given-names></name>;
<name><surname>Moore</surname><given-names>R.
J.</given-names></name>; <name><surname>Kyle</surname><given-names>J. E.</given-names></name>;
<name><surname>Nakayasu</surname><given-names>E.
S.</given-names></name>; <name><surname>Metz</surname><given-names>T. O.</given-names></name></person-group><article-title>Metabolite, Protein, and Lipid Extraction (MPLEx): A
Method That Simultaneously Inactivates Middle East Respiratory
Syndrome Coronavirus and Allows Analysis of Multiple Host Cell
Components Following Infection</article-title>. In <source>MERS
Coronavirus: Methods and Protocols</source>; <person-group person-group-type="editor"><name><surname>Vijay</surname><given-names>R.</given-names></name></person-group>, Ed.;
Methods in Molecular Biology; <publisher-name>Springer
US</publisher-name>: <publisher-loc>New York</publisher-loc>,
<year>2020</year>; pp
<fpage>173</fpage>&#x02013;<lpage>194</lpage>. DOI:
<pub-id pub-id-type="doi">10.1007/978-1-0716-0211-9_14</pub-id>.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Byers</surname><given-names>N. M.</given-names></name>; <name><surname>Fleshman</surname><given-names>A. C.</given-names></name>; <name><surname>Perera</surname><given-names>R.</given-names></name>; <name><surname>Molins</surname><given-names>C. R.</given-names></name>
<article-title>Metabolomic Insights into Human Arboviral Infections:
Dengue, Chikungunya, and Zika Viruses</article-title>. <source>Viruses</source>
<year>2019</year>, <volume>11</volume> (<issue>3</issue>), <fpage>225</fpage><pub-id pub-id-type="doi">10.3390/v11030225</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Chotiwan</surname><given-names>N.</given-names></name>; <name><surname>Andre</surname><given-names>B. G.</given-names></name>; <name><surname>Sanchez-Vargas</surname><given-names>I.</given-names></name>; <name><surname>Islam</surname><given-names>M. N.</given-names></name>; <name><surname>Grabowski</surname><given-names>J. M.</given-names></name>; <name><surname>Hopf-Jannasch</surname><given-names>A.</given-names></name>; <name><surname>Gough</surname><given-names>E.</given-names></name>; <name><surname>Nakayasu</surname><given-names>E.</given-names></name>; <name><surname>Blair</surname><given-names>C. D.</given-names></name>; <name><surname>Belisle</surname><given-names>J. T.</given-names></name>; <name><surname>Hill</surname><given-names>C. A.</given-names></name>; <name><surname>Kuhn</surname><given-names>R. J.</given-names></name>; <name><surname>Perera</surname><given-names>R.</given-names></name>
<article-title>Dynamic Remodeling of Lipids Coincides with Dengue
Virus Replication in the Midgut of Aedes Aegypti
Mosquitoes</article-title>. <source>PLoS Pathog.</source>
<year>2018</year>, <volume>14</volume> (<issue>2</issue>), <elocation-id>e1006853</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006853</pub-id>.<pub-id pub-id-type="pmid">29447265</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Singhal</surname><given-names>N.</given-names></name>; <name><surname>Kumar</surname><given-names>M.</given-names></name>; <name><surname>Kanaujia</surname><given-names>P. K.</given-names></name>; <name><surname>Virdi</surname><given-names>J. S.</given-names></name>
<article-title>MALDI-TOF Mass Spectrometry: An Emerging Technology for
Microbial Identification and Diagnosis</article-title>. <source>Front. Microbiol.</source>
<year>2015</year>, <volume>6</volume>, <fpage>x</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00791</pub-id>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Zhou</surname><given-names>S.</given-names></name>; <name><surname>Liu</surname><given-names>R.</given-names></name>; <name><surname>Zhao</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>C.</given-names></name>; <name><surname>Wei</surname><given-names>Y.</given-names></name>
<article-title>Viral Proteomics: The Emerging Cutting-Edge of Virus
Research</article-title>. <source>Sci. China: Life Sci.</source>
<year>2011</year>, <volume>54</volume> (<issue>6</issue>), <fpage>502</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-011-4177-7</pub-id>.<pub-id pub-id-type="pmid">21706410</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Coombs</surname><given-names>K. M.</given-names></name>; <name><surname>Berard</surname><given-names>A.</given-names></name>; <name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>Krokhin</surname><given-names>O.</given-names></name>; <name><surname>Meng</surname><given-names>X.</given-names></name>; <name><surname>Cortens</surname><given-names>J. P.</given-names></name>; <name><surname>Kobasa</surname><given-names>D.</given-names></name>; <name><surname>Wilkins</surname><given-names>J.</given-names></name>; <name><surname>Brown</surname><given-names>E. G.</given-names></name>
<article-title>Quantitative Proteomic Analyses of Influenza
Virus-Infected Cultured Human Lung Cells</article-title>. <source>J. Virol.</source>
<year>2010</year>, <volume>84</volume> (<issue>20</issue>), <fpage>10888</fpage>&#x02013;<lpage>10906</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00431-10</pub-id>.<pub-id pub-id-type="pmid">20702633</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Puttamallesh</surname><given-names>V. N.</given-names></name>; <name><surname>Sreenivasamurthy</surname><given-names>S. K.</given-names></name>; <name><surname>Singh</surname><given-names>P. K.</given-names></name>; <name><surname>Harsha</surname><given-names>H. C.</given-names></name>; <name><surname>Ganjiwale</surname><given-names>A.</given-names></name>; <name><surname>Broor</surname><given-names>S.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>; <name><surname>Narayana</surname><given-names>J.</given-names></name>; <name><surname>Prasad</surname><given-names>T. S. K.</given-names></name>
<article-title>Proteomic Profiling of Serum Samples from
Chikungunya-Infected Patients Provides Insights into Host
Response</article-title>. <source>Clin. Proteomics</source>
<year>2013</year>, <volume>10</volume> (<issue>1</issue>), <fpage>14</fpage><pub-id pub-id-type="doi">10.1186/1559-0275-10-14</pub-id>.<pub-id pub-id-type="pmid">24124767</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Chiu</surname><given-names>H.-C.</given-names></name>; <name><surname>Hannemann</surname><given-names>H.</given-names></name>; <name><surname>Heesom</surname><given-names>K. J.</given-names></name>; <name><surname>Matthews</surname><given-names>D. A.</given-names></name>; <name><surname>Davidson</surname><given-names>A. D.</given-names></name>
<article-title>High-Throughput Quantitative Proteomic Analysis of
Dengue Virus Type 2 Infected A549 Cells</article-title>. <source>PLoS One</source>
<year>2014</year>, <volume>9</volume> (<issue>3</issue>), <elocation-id>e93305</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0093305</pub-id>.<pub-id pub-id-type="pmid">24671231</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Scaturro</surname><given-names>P.</given-names></name>; <name><surname>Kastner</surname><given-names>A. L.</given-names></name>; <name><surname>Pichlmair</surname><given-names>A.</given-names></name>
<article-title>Chasing Intracellular Zika Virus Using
Proteomics</article-title>. <source>Viruses</source>
<year>2019</year>, <volume>11</volume> (<issue>9</issue>), <fpage>878</fpage><pub-id pub-id-type="doi">10.3390/v11090878</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Garc&#x000ed;a-Dorival</surname><given-names>I.</given-names></name>; <name><surname>Wu</surname><given-names>W.</given-names></name>; <name><surname>Armstrong</surname><given-names>S. D.</given-names></name>; <name><surname>Barr</surname><given-names>J. N.</given-names></name>; <name><surname>Carroll</surname><given-names>M. W.</given-names></name>; <name><surname>Hewson</surname><given-names>R.</given-names></name>; <name><surname>Hiscox</surname><given-names>J. A.</given-names></name>
<article-title>Elucidation of the Cellular Interactome of Ebola Virus
Nucleoprotein and Identification of Therapeutic
Targets</article-title>. <source>J. Proteome Res.</source>
<year>2016</year>, <volume>15</volume> (<issue>12</issue>), <fpage>4290</fpage>&#x02013;<lpage>4303</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00337</pub-id>.<pub-id pub-id-type="pmid">27786485</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Raj</surname><given-names>V. S.</given-names></name>; <name><surname>Lamers</surname><given-names>M. M.</given-names></name>; <name><surname>Smits</surname><given-names>S. L.</given-names></name>; <name><surname>Demmers</surname><given-names>J. A. A.</given-names></name>; <name><surname>Mou</surname><given-names>H.</given-names></name>; <name><surname>Bosch</surname><given-names>B.-J.</given-names></name>; <name><surname>Haagmans</surname><given-names>B. L.</given-names></name>
<article-title>Identification of Protein Receptors for Coronaviruses
by Mass Spectrometry</article-title>. <source>Methods Mol. Biol.</source>
<year>2015</year>, <volume>1282</volume>, <fpage>165</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2438-7_15</pub-id>.<pub-id pub-id-type="pmid">25720480</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Gordon</surname><given-names>D. E.</given-names></name>; <name><surname>Jang</surname><given-names>G. M.</given-names></name>; <name><surname>Bouhaddou</surname><given-names>M.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Obernier</surname><given-names>K.</given-names></name>; <name><surname>White</surname><given-names>K. M.</given-names></name>; <name><surname>O&#x02019;Meara</surname><given-names>M. J.</given-names></name>; <name><surname>Rezelj</surname><given-names>V. V.</given-names></name>; <name><surname>Guo</surname><given-names>J. Z.</given-names></name>; <name><surname>Swaney</surname><given-names>D. L.</given-names></name>; <name><surname>Tummino</surname><given-names>T. A.</given-names></name>; <name><surname>H&#x000fc;ttenhain</surname><given-names>R.</given-names></name>; <name><surname>Kaake</surname><given-names>R. M.</given-names></name>; <name><surname>Richards</surname><given-names>A. L.</given-names></name>; <name><surname>Tutuncuoglu</surname><given-names>B.</given-names></name>; <name><surname>Foussard</surname><given-names>H.</given-names></name>; <name><surname>Batra</surname><given-names>J.</given-names></name>; <name><surname>Haas</surname><given-names>K.</given-names></name>; <name><surname>Modak</surname><given-names>M.</given-names></name>; <name><surname>Kim</surname><given-names>M.</given-names></name>; <name><surname>Haas</surname><given-names>P.</given-names></name>; <name><surname>Polacco</surname><given-names>B. J.</given-names></name>; <name><surname>Braberg</surname><given-names>H.</given-names></name>; <name><surname>Fabius</surname><given-names>J. M.</given-names></name>; <name><surname>Eckhardt</surname><given-names>M.</given-names></name>; <name><surname>Soucheray</surname><given-names>M.</given-names></name>; <name><surname>Bennett</surname><given-names>M. J.</given-names></name>; <name><surname>Cakir</surname><given-names>M.</given-names></name>; <name><surname>McGregor</surname><given-names>M. J.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Meyer</surname><given-names>B.</given-names></name>; <name><surname>Roesch</surname><given-names>F.</given-names></name>; <name><surname>Vallet</surname><given-names>T.</given-names></name>; <name><surname>Mac Kain</surname><given-names>A.</given-names></name>; <name><surname>Miorin</surname><given-names>L.</given-names></name>; <name><surname>Moreno</surname><given-names>E.</given-names></name>; <name><surname>Naing</surname><given-names>Z. Z. C.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Peng</surname><given-names>S.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Shen</surname><given-names>W.</given-names></name>; <name><surname>Kirby</surname><given-names>I. T.</given-names></name>; <name><surname>Melnyk</surname><given-names>J. E.</given-names></name>; <name><surname>Chorba</surname><given-names>J. S.</given-names></name>; <name><surname>Lou</surname><given-names>K.</given-names></name>; <name><surname>Dai</surname><given-names>S. A.</given-names></name>; <name><surname>Barrio-Hernandez</surname><given-names>I.</given-names></name>; <name><surname>Memon</surname><given-names>D.</given-names></name>; <name><surname>Hernandez-Armenta</surname><given-names>C.</given-names></name>; <name><surname>Lyu</surname><given-names>J.</given-names></name>; <name><surname>Mathy</surname><given-names>C. J. P.</given-names></name>; <name><surname>Perica</surname><given-names>T.</given-names></name>; <name><surname>Pilla</surname><given-names>K. B.</given-names></name>; <name><surname>Ganesan</surname><given-names>S. J.</given-names></name>; <name><surname>Saltzberg</surname><given-names>D. J.</given-names></name>; <name><surname>Rakesh</surname><given-names>R.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Rosenthal</surname><given-names>S. B.</given-names></name>; <name><surname>Calviello</surname><given-names>L.</given-names></name>; <name><surname>Venkataramanan</surname><given-names>S.</given-names></name>; <name><surname>Liboy-Lugo</surname><given-names>J.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>X.-P.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Wankowicz</surname><given-names>S. A.</given-names></name>; <name><surname>Bohn</surname><given-names>M.</given-names></name>; <name><surname>Safari</surname><given-names>M.</given-names></name>; <name><surname>Ugur</surname><given-names>F. S.</given-names></name>; <name><surname>Koh</surname><given-names>C.</given-names></name>; <name><surname>Savar</surname><given-names>N. S.</given-names></name>; <name><surname>Tran</surname><given-names>Q. D.</given-names></name>; <name><surname>Shengjuler</surname><given-names>D.</given-names></name>; <name><surname>Fletcher</surname><given-names>S. J.</given-names></name>; <name><surname>O&#x02019;Neal</surname><given-names>M. C.</given-names></name>; <name><surname>Cai</surname><given-names>Y.</given-names></name>; <name><surname>Chang</surname><given-names>J. C. J.</given-names></name>; <name><surname>Broadhurst</surname><given-names>D. J.</given-names></name>; <name><surname>Klippsten</surname><given-names>S.</given-names></name>; <name><surname>Sharp</surname><given-names>P. P.</given-names></name>; <name><surname>Wenzell</surname><given-names>N. A.</given-names></name>; <name><surname>Kuzuoglu-Ozturk</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>H.-Y.</given-names></name>; <name><surname>Trenker</surname><given-names>R.</given-names></name>; <name><surname>Young</surname><given-names>J. M.</given-names></name>; <name><surname>Cavero</surname><given-names>D. A.</given-names></name>; <name><surname>Hiatt</surname><given-names>J.</given-names></name>; <name><surname>Roth</surname><given-names>T. L.</given-names></name>; <name><surname>Rathore</surname><given-names>U.</given-names></name>; <name><surname>Subramanian</surname><given-names>A.</given-names></name>; <name><surname>Noack</surname><given-names>J.</given-names></name>; <name><surname>Hubert</surname><given-names>M.</given-names></name>; <name><surname>Stroud</surname><given-names>R. M.</given-names></name>; <name><surname>Frankel</surname><given-names>A. D.</given-names></name>; <name><surname>Rosenberg</surname><given-names>O. S.</given-names></name>; <name><surname>Verba</surname><given-names>K. A.</given-names></name>; <name><surname>Agard</surname><given-names>D. A.</given-names></name>; <name><surname>Ott</surname><given-names>M.</given-names></name>; <name><surname>Emerman</surname><given-names>M.</given-names></name>; <name><surname>Jura</surname><given-names>N.</given-names></name>; <name><surname>von Zastrow</surname><given-names>M.</given-names></name>; <name><surname>Verdin</surname><given-names>E.</given-names></name>; <name><surname>Ashworth</surname><given-names>A.</given-names></name>; <name><surname>Schwartz</surname><given-names>O.</given-names></name>; <name><surname>d&#x02019;Enfert</surname><given-names>C.</given-names></name>; <name><surname>Mukherjee</surname><given-names>S.</given-names></name>; <name><surname>Jacobson</surname><given-names>M.</given-names></name>; <name><surname>Malik</surname><given-names>H. S.</given-names></name>; <name><surname>Fujimori</surname><given-names>D. G.</given-names></name>; <name><surname>Ideker</surname><given-names>T.</given-names></name>; <name><surname>Craik</surname><given-names>C. S.</given-names></name>; <name><surname>Floor</surname><given-names>S. N.</given-names></name>; <name><surname>Fraser</surname><given-names>J. S.</given-names></name>; <name><surname>Gross</surname><given-names>J. D.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name>; <name><surname>Roth</surname><given-names>B. L.</given-names></name>; <name><surname>Ruggero</surname><given-names>D.</given-names></name>; <name><surname>Taunton</surname><given-names>J.</given-names></name>; <name><surname>Kortemme</surname><given-names>T.</given-names></name>; <name><surname>Beltrao</surname><given-names>P.</given-names></name>; <name><surname>Vignuzzi</surname><given-names>M.</given-names></name>; <name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name>; <name><surname>Shokat</surname><given-names>K. M.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name>; <name><surname>Krogan</surname><given-names>N. J.</given-names></name>
<article-title>A SARS-CoV-2 Protein Interaction Map Reveals Targets
for Drug Repurposing</article-title>. <source>Nature</source>
<year>2020</year>, <volume>583</volume> (<issue>7816</issue>), <fpage>459</fpage>&#x02013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id>.<pub-id pub-id-type="pmid">32353859</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Shen</surname><given-names>B.</given-names></name>; <name><surname>Yi</surname><given-names>X.</given-names></name>; <name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Bi</surname><given-names>X.</given-names></name>; <name><surname>Du</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Quan</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>F.</given-names></name>; <name><surname>Sun</surname><given-names>R.</given-names></name>; <name><surname>Qian</surname><given-names>L.</given-names></name>; <name><surname>Ge</surname><given-names>W.</given-names></name>; <name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Liang</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>He</surname><given-names>Z.</given-names></name>; <name><surname>Chen</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Yan</surname><given-names>H.</given-names></name>; <name><surname>Zheng</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Zhu</surname><given-names>J.</given-names></name>; <name><surname>Kong</surname><given-names>Z.</given-names></name>; <name><surname>Kang</surname><given-names>Z.</given-names></name>; <name><surname>Liang</surname><given-names>X.</given-names></name>; <name><surname>Ding</surname><given-names>X.</given-names></name>; <name><surname>Ruan</surname><given-names>G.</given-names></name>; <name><surname>Xiang</surname><given-names>N.</given-names></name>; <name><surname>Cai</surname><given-names>X.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Xiao</surname><given-names>Q.</given-names></name>; <name><surname>Lu</surname><given-names>T.</given-names></name>; <name><surname>Zhu</surname><given-names>Y. J.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Guo</surname><given-names>T.</given-names></name>
<article-title>Proteomic and Metabolomic Characterization of COVID-19
Patient Sera</article-title>. <source>SSRN J.</source>
<year>2020</year>, <fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.2139/ssrn.3570565</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Sun</surname><given-names>W.</given-names></name>; <name><surname>Ding</surname><given-names>B.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>P.</given-names></name>; <name><surname>Zhu</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>N.</given-names></name>; <name><surname>Chang</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Bai</surname><given-names>C.</given-names></name>; <name><surname>Xu</surname><given-names>P.</given-names></name>
<article-title>Urine Proteome of COVID-19 Patients</article-title>. <source>medRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.05.02.20088666</pub-id>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Bezstarosti</surname><given-names>K.</given-names></name>; <name><surname>Lamers</surname><given-names>M. M.</given-names></name>; <name><surname>Haagmans</surname><given-names>B. L.</given-names></name>; <name><surname>Demmers</surname><given-names>J. A. A.</given-names></name>
<article-title>Targeted Proteomics for the Detection of SARS-CoV-2
Proteins</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.04.23.057810</pub-id>.</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Messner</surname><given-names>C. B.</given-names></name>; <name><surname>Demichev</surname><given-names>V.</given-names></name>; <name><surname>Wendisch</surname><given-names>D.</given-names></name>; <name><surname>Michalick</surname><given-names>L.</given-names></name>; <name><surname>White</surname><given-names>M.</given-names></name>; <name><surname>Freiwald</surname><given-names>A.</given-names></name>; <name><surname>Textoris-Taube</surname><given-names>K.</given-names></name>; <name><surname>Vernardis</surname><given-names>S. I.</given-names></name>; <name><surname>Egger</surname><given-names>A.-S.</given-names></name>; <name><surname>Kreidl</surname><given-names>M.</given-names></name>; <name><surname>Ludwig</surname><given-names>D.</given-names></name>; <name><surname>Kilian</surname><given-names>C.</given-names></name>; <name><surname>Agostini</surname><given-names>F.</given-names></name>; <name><surname>Zelezniak</surname><given-names>A.</given-names></name>; <name><surname>Thibeault</surname><given-names>C.</given-names></name>; <name><surname>Pfeiffer</surname><given-names>M.</given-names></name>; <name><surname>Hippenstiel</surname><given-names>S.</given-names></name>; <name><surname>Hocke</surname><given-names>A.</given-names></name>; <name><surname>Kalle von</surname><given-names>C.</given-names></name>; <name><surname>Campbell</surname><given-names>A.</given-names></name>; <name><surname>Hayward</surname><given-names>C.</given-names></name>; <name><surname>Porteous</surname><given-names>D. J.</given-names></name>; <name><surname>Marioni</surname><given-names>R. E.</given-names></name>; <name><surname>Langenberg</surname><given-names>C.</given-names></name>; <name><surname>Lilley</surname><given-names>K. S.</given-names></name>; <name><surname>Kuebler</surname><given-names>W. M.</given-names></name>; <name><surname>Muelleder</surname><given-names>M.</given-names></name>; <name><surname>Drosten</surname><given-names>C.</given-names></name>; <name><surname>Witzenrath</surname><given-names>M.</given-names></name>; <name><surname>Kurth</surname><given-names>F.</given-names></name>; <name><surname>Sander</surname><given-names>L. E.</given-names></name>; <name><surname>Ralser</surname><given-names>M.</given-names></name>
<article-title>Clinical Classifiers of COVID-19 Infection from Novel
Ultra-High-Throughput Proteomics</article-title>. <source>medRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.04.27.20081810</pub-id>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>M.</given-names></name>; <name><surname>Tian</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>C.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Wu</surname><given-names>P.</given-names></name>; <name><surname>Xiao</surname><given-names>Z.</given-names></name>; <name><surname>Qu</surname><given-names>Y.</given-names></name>; <name><surname>Yin</surname><given-names>Y.</given-names></name>; <name><surname>Fu</surname><given-names>J.</given-names></name>; <name><surname>Zhu</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Peng</surname><given-names>C.</given-names></name>; <name><surname>Zhu</surname><given-names>T.</given-names></name>; <name><surname>Liang</surname><given-names>Q.</given-names></name>
<article-title>Virus-Host Interactome and Proteomic Survey of PMBCs
from COVID-19 Patients Reveal Potential Virulence Factors
Influencing SARS-CoV-2 Pathogenesis</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.03.31.019216</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Ihling</surname><given-names>C.</given-names></name>; <name><surname>T&#x000e4;nzler</surname><given-names>D.</given-names></name>; <name><surname>Hagemann</surname><given-names>S.</given-names></name>; <name><surname>Kehlen</surname><given-names>A.</given-names></name>; <name><surname>H&#x000fc;ttelmaier</surname><given-names>S.</given-names></name>; <name><surname>Arlt</surname><given-names>C.</given-names></name>; <name><surname>Sinz</surname><given-names>A.</given-names></name>
<article-title>Mass Spectrometric Identification of SARS-CoV-2
Proteins from Gargle Solution Samples of COVID-19
Patients</article-title>. <source>J. Proteome Res.</source>
<year>2020</year>, <fpage>x</fpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.0c00280</pub-id>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Bojkova</surname><given-names>D.</given-names></name>; <name><surname>Klann</surname><given-names>K.</given-names></name>; <name><surname>Koch</surname><given-names>B.</given-names></name>; <name><surname>Widera</surname><given-names>M.</given-names></name>; <name><surname>Krause</surname><given-names>D.</given-names></name>; <name><surname>Ciesek</surname><given-names>S.</given-names></name>; <name><surname>Cinatl</surname><given-names>J.</given-names></name>; <name><surname>M&#x000fc;nch</surname><given-names>C.</given-names></name>
<article-title>Proteomics of SARS-CoV-2-Infected Host Cells Reveals
Therapy Targets</article-title>. <source>Nature</source>
<year>2020</year>, <volume>583</volume>, <fpage>469</fpage><pub-id pub-id-type="doi">10.1038/s41586-020-2332-7</pub-id>.<pub-id pub-id-type="pmid">32408336</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Rocca</surname><given-names>M. F.</given-names></name>; <name><surname>Zintgraff</surname><given-names>J. C.</given-names></name>; <name><surname>Dattero</surname><given-names>M. E.</given-names></name>; <name><surname>Santos</surname><given-names>L. S.</given-names></name>; <name><surname>Ledesma</surname><given-names>M.</given-names></name>; <name><surname>Vay</surname><given-names>C.</given-names></name>; <name><surname>Prieto</surname><given-names>M.</given-names></name>; <name><surname>Benedetti</surname><given-names>E.</given-names></name>; <name><surname>Avaro</surname><given-names>M.</given-names></name>; <name><surname>Russo</surname><given-names>M.</given-names></name>; <name><surname>Nachtigall</surname><given-names>F. M.</given-names></name>; <name><surname>Baumeister</surname><given-names>E.</given-names></name>
<article-title>A Combined Approach of MALDI-TOF Mass Spectrometry and
Multivariate Analysis as a Potential Tool for the Detection of
SARS-CoV-2 Virus in Nasopharyngeal Swabs</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.05.07.082925</pub-id>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Adamo</surname><given-names>R.</given-names></name>; <name><surname>Sonnino</surname><given-names>S.</given-names></name>
<article-title>Impact of Glycoscience in Fighting
Covid-19</article-title>. <source>Glycoconjugate J.</source>
<year>2020</year>, <volume>37</volume> (<issue>4</issue>), <fpage>511</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1007/s10719-020-09929-9</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name><surname>Berndsen</surname><given-names>Z. T.</given-names></name>; <name><surname>Raghwani</surname><given-names>J.</given-names></name>; <name><surname>Seabright</surname><given-names>G. E.</given-names></name>; <name><surname>Allen</surname><given-names>J. D.</given-names></name>; <name><surname>Pybus</surname><given-names>O. G.</given-names></name>; <name><surname>McLellan</surname><given-names>J. S.</given-names></name>; <name><surname>Wilson</surname><given-names>I. A.</given-names></name>; <name><surname>Bowden</surname><given-names>T. A.</given-names></name>; <name><surname>Ward</surname><given-names>A. B.</given-names></name>; <name><surname>Crispin</surname><given-names>M.</given-names></name>
<article-title>Vulnerabilities in Coronavirus Glycan Shields despite
Extensive Glycosylation</article-title>. <source>Nat. Commun.</source>
<year>2020</year>, <volume>11</volume> (<issue>1</issue>), <fpage>2688</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-16567-0</pub-id>.<pub-id pub-id-type="pmid">32461612</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Shajahan</surname><given-names>A.</given-names></name>; <name><surname>Archer-Hartmann</surname><given-names>S.</given-names></name>; <name><surname>Supekar</surname><given-names>N. T.</given-names></name>; <name><surname>Gleinich</surname><given-names>A. S.</given-names></name>; <name><surname>Heiss</surname><given-names>C.</given-names></name>; <name><surname>Azadi</surname><given-names>P.</given-names></name>
<article-title>Comprehensive Characterization of N- and O-
Glycosylation of SARS-CoV-2 Human Receptor Angiotensin
Converting Enzyme 2</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.05.01.071688</pub-id>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Zhao</surname><given-names>P.</given-names></name>; <name><surname>Praissman</surname><given-names>J. L.</given-names></name>; <name><surname>Grant</surname><given-names>O. C.</given-names></name>; <name><surname>Cai</surname><given-names>Y.</given-names></name>; <name><surname>Xiao</surname><given-names>T.</given-names></name>; <name><surname>Rosenbalm</surname><given-names>K. E.</given-names></name>; <name><surname>Aoki</surname><given-names>K.</given-names></name>; <name><surname>Kellman</surname><given-names>B. P.</given-names></name>; <name><surname>Bridger</surname><given-names>R.</given-names></name>; <name><surname>Barouch</surname><given-names>D. H.</given-names></name>; <name><surname>Brindley</surname><given-names>M. A.</given-names></name>; <name><surname>Lewis</surname><given-names>N. E.</given-names></name>; <name><surname>Tiemeyer</surname><given-names>M.</given-names></name>; <name><surname>Chen</surname><given-names>B.</given-names></name>; <name><surname>Woods</surname><given-names>R. J.</given-names></name>; <name><surname>Wells</surname><given-names>L.</given-names></name>
<article-title>Virus-Receptor Interactions of Glycosylated SARS-CoV-2
Spike and Human ACE2 Receptor</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.06.25.172403</pub-id>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="book" id="cit51"><person-group person-group-type="allauthors"><name><surname>Mahmud</surname><given-names>I.</given-names></name>;
<name><surname>Garrett</surname><given-names>T.
J.</given-names></name>;
<name><surname>Garrett</surname><given-names>T.
J.</given-names></name></person-group><source>Lipidomics in Human Cancer and Malnutrition</source>;
<publisher-name>Taylor and Francis</publisher-name>,
<year>2020</year>. <pub-id pub-id-type="doi">10.1201/9780429461385-2</pub-id> (accessed
2020-05-12).</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Wenk</surname><given-names>M. R.</given-names></name>
<article-title>Lipidomics of Host-Pathogen
Interactions</article-title>. <source>FEBS Lett.</source>
<year>2006</year>, <volume>580</volume> (<issue>23</issue>), <fpage>5541</fpage>&#x02013;<lpage>5551</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2006.07.007</pub-id>.<pub-id pub-id-type="pmid">16859687</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Perera</surname><given-names>R.</given-names></name>; <name><surname>Riley</surname><given-names>C.</given-names></name>; <name><surname>Isaac</surname><given-names>G.</given-names></name>; <name><surname>Hopf-Jannasch</surname><given-names>A. S.</given-names></name>; <name><surname>Moore</surname><given-names>R. J.</given-names></name>; <name><surname>Weitz</surname><given-names>K. W.</given-names></name>; <name><surname>Pasa-Tolic</surname><given-names>L.</given-names></name>; <name><surname>Metz</surname><given-names>T. O.</given-names></name>; <name><surname>Adamec</surname><given-names>J.</given-names></name>; <name><surname>Kuhn</surname><given-names>R. J.</given-names></name>
<article-title>Dengue Virus Infection Perturbs Lipid Homeostasis in
Infected Mosquito Cells</article-title>. <source>PLoS Pathog.</source>
<year>2012</year>, <volume>8</volume> (<issue>3</issue>), <elocation-id>e1002584</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002584</pub-id>.<pub-id pub-id-type="pmid">22457619</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Welsch</surname><given-names>S.</given-names></name>; <name><surname>Miller</surname><given-names>S.</given-names></name>; <name><surname>Romero-Brey</surname><given-names>I.</given-names></name>; <name><surname>Merz</surname><given-names>A.</given-names></name>; <name><surname>Bleck</surname><given-names>C. K. E.</given-names></name>; <name><surname>Walther</surname><given-names>P.</given-names></name>; <name><surname>Fuller</surname><given-names>S. D.</given-names></name>; <name><surname>Antony</surname><given-names>C.</given-names></name>; <name><surname>Krijnse-Locker</surname><given-names>J.</given-names></name>; <name><surname>Bartenschlager</surname><given-names>R.</given-names></name>
<article-title>Composition and Three-Dimensional Architecture of the
Dengue Virus Replication and Assembly Sites</article-title>. <source>Cell Host Microbe</source>
<year>2009</year>, <volume>5</volume> (<issue>4</issue>), <fpage>365</fpage>&#x02013;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2009.03.007</pub-id>.<pub-id pub-id-type="pmid">19380115</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Chatel-Chaix</surname><given-names>L.</given-names></name>; <name><surname>Bartenschlager</surname><given-names>R.</given-names></name>
<article-title>Dengue Virus- and Hepatitis C Virus-Induced Replication
and Assembly Compartments: The Enemy inside--Caught in the
Web</article-title>. <source>J. Virol.</source>
<year>2014</year>, <volume>88</volume> (<issue>11</issue>), <fpage>5907</fpage>&#x02013;<lpage>5911</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.03404-13</pub-id>.<pub-id pub-id-type="pmid">24623440</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Heaton</surname><given-names>N. S.</given-names></name>; <name><surname>Randall</surname><given-names>G.</given-names></name>
<article-title>Multifaceted Roles for Lipids in Viral
Infection</article-title>. <source>Trends Microbiol.</source>
<year>2011</year>, <volume>19</volume> (<issue>7</issue>), <fpage>368</fpage>&#x02013;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2011.03.007</pub-id>.<pub-id pub-id-type="pmid">21530270</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Taube</surname><given-names>S.</given-names></name>; <name><surname>Jiang</surname><given-names>M.</given-names></name>; <name><surname>Wobus</surname><given-names>C. E.</given-names></name>
<article-title>Glycosphingolipids as Receptors for Non-Enveloped
Viruses</article-title>. <source>Viruses</source>
<year>2010</year>, <volume>2</volume> (<issue>4</issue>), <fpage>1011</fpage>&#x02013;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.3390/v2041011</pub-id>.<pub-id pub-id-type="pmid">21994669</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Taube</surname><given-names>S.</given-names></name>; <name><surname>Perry</surname><given-names>J. W.</given-names></name>; <name><surname>Yetming</surname><given-names>K.</given-names></name>; <name><surname>Patel</surname><given-names>S. P.</given-names></name>; <name><surname>Auble</surname><given-names>H.</given-names></name>; <name><surname>Shu</surname><given-names>L.</given-names></name>; <name><surname>Nawar</surname><given-names>H. F.</given-names></name>; <name><surname>Lee</surname><given-names>C. H.</given-names></name>; <name><surname>Connell</surname><given-names>T. D.</given-names></name>; <name><surname>Shayman</surname><given-names>J. A.</given-names></name>; <name><surname>Wobus</surname><given-names>C. E.</given-names></name>
<article-title>Ganglioside-Linked Terminal Sialic Acid Moieties on
Murine Macrophages Function as Attachment Receptors for Murine
Noroviruses</article-title>. <source>J. Virol.</source>
<year>2009</year>, <volume>83</volume> (<issue>9</issue>), <fpage>4092</fpage>&#x02013;<lpage>4101</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02245-08</pub-id>.<pub-id pub-id-type="pmid">19244326</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Agnello</surname><given-names>V.</given-names></name>; <name><surname>Abel</surname><given-names>G.</given-names></name>; <name><surname>Elfahal</surname><given-names>M.</given-names></name>; <name><surname>Knight</surname><given-names>G. B.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.-X.</given-names></name>
<article-title>Hepatitis C Virus and Other Flaviviridae Viruses Enter
Cells via Low Density Lipoprotein Receptor</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>1999</year>, <volume>96</volume> (<issue>22</issue>), <fpage>12766</fpage>&#x02013;<lpage>12771</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.22.12766</pub-id>.<pub-id pub-id-type="pmid">10535997</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Zaitseva</surname><given-names>E.</given-names></name>; <name><surname>Yang</surname><given-names>S.-T.</given-names></name>; <name><surname>Melikov</surname><given-names>K.</given-names></name>; <name><surname>Pourmal</surname><given-names>S.</given-names></name>; <name><surname>Chernomordik</surname><given-names>L. V.</given-names></name>
<article-title>Dengue Virus Ensures Its Fusion in Late Endosomes Using
Compartment-Specific Lipids</article-title>. <source>PLoS Pathog.</source>
<year>2010</year>, <volume>6</volume> (<issue>10</issue>), <elocation-id>e1001131</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1001131</pub-id>.<pub-id pub-id-type="pmid">20949067</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Chazal</surname><given-names>N.</given-names></name>; <name><surname>Gerlier</surname><given-names>D.</given-names></name>
<article-title>Virus Entry, Assembly, Budding, and Membrane
Rafts</article-title>. <source>Microbiol. Mol. Biol. Rev.</source>
<year>2003</year>, <volume>67</volume> (<issue>2</issue>), <fpage>226</fpage>&#x02013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.67.2.226-237.2003</pub-id>.<pub-id pub-id-type="pmid">12794191</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Berger</surname><given-names>K. L.</given-names></name>; <name><surname>Cooper</surname><given-names>J. D.</given-names></name>; <name><surname>Heaton</surname><given-names>N. S.</given-names></name>; <name><surname>Yoon</surname><given-names>R.</given-names></name>; <name><surname>Oakland</surname><given-names>T. E.</given-names></name>; <name><surname>Jordan</surname><given-names>T. X.</given-names></name>; <name><surname>Mateu</surname><given-names>G.</given-names></name>; <name><surname>Grakoui</surname><given-names>A.</given-names></name>; <name><surname>Randall</surname><given-names>G.</given-names></name>
<article-title>Roles for Endocytic Trafficking and
Phosphatidylinositol 4-Kinase III Alpha in Hepatitis C Virus
Replication</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2009</year>, <volume>106</volume> (<issue>18</issue>), <fpage>7577</fpage>&#x02013;<lpage>7582</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0902693106</pub-id>.<pub-id pub-id-type="pmid">19376974</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Tai</surname><given-names>A. W.</given-names></name>; <name><surname>Benita</surname><given-names>Y.</given-names></name>; <name><surname>Peng</surname><given-names>L. F.</given-names></name>; <name><surname>Kim</surname><given-names>S.-S.</given-names></name>; <name><surname>Sakamoto</surname><given-names>N.</given-names></name>; <name><surname>Xavier</surname><given-names>R. J.</given-names></name>; <name><surname>Chung</surname><given-names>R. T.</given-names></name>
<article-title>A Functional Genomic Screen Identifies Cellular
Cofactors of Hepatitis C Virus Replication</article-title>. <source>Cell Host Microbe</source>
<year>2009</year>, <volume>5</volume> (<issue>3</issue>), <fpage>298</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2009.02.001</pub-id>.<pub-id pub-id-type="pmid">19286138</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Mackenzie</surname><given-names>J. M.</given-names></name>; <name><surname>Khromykh</surname><given-names>A. A.</given-names></name>; <name><surname>Parton</surname><given-names>R. G.</given-names></name>
<article-title>Cholesterol Manipulation by West Nile Virus Perturbs
the Cellular Immune Response</article-title>. <source>Cell Host Microbe</source>
<year>2007</year>, <volume>2</volume> (<issue>4</issue>), <fpage>229</fpage>&#x02013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2007.09.003</pub-id>.<pub-id pub-id-type="pmid">18005741</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Rothwell</surname><given-names>C.</given-names></name>; <name><surname>LeBreton</surname><given-names>A.</given-names></name>; <name><surname>Young Ng</surname><given-names>C.</given-names></name>; <name><surname>Lim</surname><given-names>J. Y. H.</given-names></name>; <name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Vasudevan</surname><given-names>S.</given-names></name>; <name><surname>Labow</surname><given-names>M.</given-names></name>; <name><surname>Gu</surname><given-names>F.</given-names></name>; <name><surname>Gaither</surname><given-names>L. A.</given-names></name>
<article-title>Cholesterol Biosynthesis Modulation Regulates Dengue
Viral Replication</article-title>. <source>Virology</source>
<year>2009</year>, <volume>389</volume> (<issue>1&#x02013;2</issue>), <fpage>8</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2009.03.025</pub-id>.<pub-id pub-id-type="pmid">19419745</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Adu-Gyamfi</surname><given-names>E.</given-names></name>; <name><surname>Johnson</surname><given-names>K. A.</given-names></name>; <name><surname>Fraser</surname><given-names>M. E.</given-names></name>; <name><surname>Scott</surname><given-names>J. L.</given-names></name>; <name><surname>Soni</surname><given-names>S. P.</given-names></name>; <name><surname>Jones</surname><given-names>K. R.</given-names></name>; <name><surname>Digman</surname><given-names>M. A.</given-names></name>; <name><surname>Gratton</surname><given-names>E.</given-names></name>; <name><surname>Tessier</surname><given-names>C. R.</given-names></name>; <name><surname>Stahelin</surname><given-names>R. V.</given-names></name>
<article-title>Host Cell Plasma Membrane Phosphatidylserine Regulates
the Assembly and Budding of Ebola Virus</article-title>. <source>J. Virol.</source>
<year>2015</year>, <volume>89</volume> (<issue>18</issue>), <fpage>9440</fpage>&#x02013;<lpage>9453</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01087-15</pub-id>.<pub-id pub-id-type="pmid">26136573</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Nanbo</surname><given-names>A.</given-names></name>; <name><surname>Maruyama</surname><given-names>J.</given-names></name>; <name><surname>Imai</surname><given-names>M.</given-names></name>; <name><surname>Ujie</surname><given-names>M.</given-names></name>; <name><surname>Fujioka</surname><given-names>Y.</given-names></name>; <name><surname>Nishide</surname><given-names>S.</given-names></name>; <name><surname>Takada</surname><given-names>A.</given-names></name>; <name><surname>Ohba</surname><given-names>Y.</given-names></name>; <name><surname>Kawaoka</surname><given-names>Y.</given-names></name>
<article-title>Ebola Virus Requires a Host Scramblase for
Externalization of Phosphatidylserine on the Surface of Viral
Particles</article-title>. <source>PLoS Pathog.</source>
<year>2018</year>, <volume>14</volume> (<issue>1</issue>), <elocation-id>e1006848</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006848</pub-id>.<pub-id pub-id-type="pmid">29338048</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Soni</surname><given-names>S. P.</given-names></name>; <name><surname>Stahelin</surname><given-names>R. V.</given-names></name>
<article-title>The Ebola Virus Matrix Protein VP40 Selectively Induces
Vesiculation from Phosphatidylserine-Enriched
Membranes</article-title>. <source>J. Biol. Chem.</source>
<year>2014</year>, <volume>289</volume> (<issue>48</issue>), <fpage>33590</fpage>&#x02013;<lpage>33597</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.586396</pub-id>.<pub-id pub-id-type="pmid">25315776</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Miller</surname><given-names>M. E.</given-names></name>; <name><surname>Adhikary</surname><given-names>S.</given-names></name>; <name><surname>Kolokoltsov</surname><given-names>A. A.</given-names></name>; <name><surname>Davey</surname><given-names>R. A.</given-names></name>
<article-title>Ebolavirus Requires Acid Sphingomyelinase Activity and
Plasma Membrane Sphingomyelin for Infection</article-title>. <source>J. Virol.</source>
<year>2012</year>, <volume>86</volume> (<issue>14</issue>), <fpage>7473</fpage>&#x02013;<lpage>7483</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00136-12</pub-id>.<pub-id pub-id-type="pmid">22573858</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Ma&#x000f1;es</surname><given-names>S.</given-names></name>; <name><surname>Del Real</surname><given-names>G.</given-names></name>; <name><surname>Mart&#x000ed;nez-A</surname><given-names>C.</given-names></name>
<article-title>Pathogens: Raft Hijackers</article-title>. <source>Nat. Rev. Immunol.</source>
<year>2003</year>, <volume>3</volume> (<issue>7</issue>), <fpage>557</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1038/nri1129</pub-id>.<pub-id pub-id-type="pmid">12876558</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Bavari</surname><given-names>S.</given-names></name>; <name><surname>Bosio</surname><given-names>C. M.</given-names></name>; <name><surname>Wiegand</surname><given-names>E.</given-names></name>; <name><surname>Ruthel</surname><given-names>G.</given-names></name>; <name><surname>Will</surname><given-names>A. B.</given-names></name>; <name><surname>Geisbert</surname><given-names>T. W.</given-names></name>; <name><surname>Hevey</surname><given-names>M.</given-names></name>; <name><surname>Schmaljohn</surname><given-names>C.</given-names></name>; <name><surname>Schmaljohn</surname><given-names>A.</given-names></name>; <name><surname>Aman</surname><given-names>M. J.</given-names></name>
<article-title>Lipid Raft Microdomains: A Gateway for
Compartmentalized Trafficking of Ebola and Marburg
Viruses</article-title>. <source>J. Exp. Med.</source>
<year>2002</year>, <volume>195</volume> (<issue>5</issue>), <fpage>593</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20011500</pub-id>.<pub-id pub-id-type="pmid">11877482</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>Takeda</surname><given-names>M.</given-names></name>; <name><surname>Leser</surname><given-names>G. P.</given-names></name>; <name><surname>Russell</surname><given-names>C. J.</given-names></name>; <name><surname>Lamb</surname><given-names>R. A.</given-names></name>
<article-title>Influenza Virus Hemagglutinin Concentrates in Lipid
Raft Microdomains for Efficient Viral Fusion</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2003</year>, <volume>100</volume> (<issue>25</issue>), <fpage>14610</fpage>&#x02013;<lpage>14617</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2235620100</pub-id>.<pub-id pub-id-type="pmid">14561897</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>Soudani</surname><given-names>N.</given-names></name>; <name><surname>Hage-Sleiman</surname><given-names>R.</given-names></name>; <name><surname>Karam</surname><given-names>W.</given-names></name>; <name><surname>Dbaibo</surname><given-names>G.</given-names></name>; <name><surname>Zaraket</surname><given-names>H.</given-names></name>
<article-title>Ceramide Suppresses Influenza A Virus Replication In
Vitro</article-title>. <source>J. Virol.</source>
<year>2019</year>, <volume>93</volume> (<issue>7</issue>), <fpage>x</fpage><pub-id pub-id-type="doi">10.1128/JVI.00053-19</pub-id>.</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>Kyle</surname><given-names>J. E.</given-names></name>; <name><surname>Burnum-Johnson</surname><given-names>K. E.</given-names></name>; <name><surname>Wendler</surname><given-names>J. P.</given-names></name>; <name><surname>Eisfeld</surname><given-names>A. J.</given-names></name>; <name><surname>Halfmann</surname><given-names>P. J.</given-names></name>; <name><surname>Watanabe</surname><given-names>T.</given-names></name>; <name><surname>Sahr</surname><given-names>F.</given-names></name>; <name><surname>Smith</surname><given-names>R. D.</given-names></name>; <name><surname>Kawaoka</surname><given-names>Y.</given-names></name>; <name><surname>Waters</surname><given-names>K. M.</given-names></name>; <name><surname>Metz</surname><given-names>T. O.</given-names></name>
<article-title>Plasma Lipidome Reveals Critical Illness and Recovery
from Human Ebola Virus Disease</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2019</year>, <volume>116</volume> (<issue>9</issue>), <fpage>3919</fpage>&#x02013;<lpage>3928</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1815356116</pub-id>.<pub-id pub-id-type="pmid">30808769</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>Yan</surname><given-names>B.</given-names></name>; <name><surname>Chu</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>D.</given-names></name>; <name><surname>Sze</surname><given-names>K.-H.</given-names></name>; <name><surname>Lai</surname><given-names>P.-M.</given-names></name>; <name><surname>Yuan</surname><given-names>S.</given-names></name>; <name><surname>Shuai</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Kao</surname><given-names>R. Y.-T.</given-names></name>; <name><surname>Chan</surname><given-names>J. F.-W.</given-names></name>; <name><surname>Yuen</surname><given-names>K.-Y.</given-names></name>
<article-title>Characterization of the Lipidomic Profile of Human
Coronavirus-Infected Cells: Implications for Lipid Metabolism
Remodeling upon Coronavirus Replication</article-title>. <source>Viruses</source>
<year>2019</year>, <volume>11</volume> (<issue>1</issue>), <fpage>73</fpage><pub-id pub-id-type="doi">10.3390/v11010073</pub-id>.</mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name><surname>Wu</surname><given-names>D.</given-names></name>; <name><surname>Shu</surname><given-names>T.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Song</surname><given-names>J.-X.</given-names></name>; <name><surname>Zhang</surname><given-names>M.</given-names></name>; <name><surname>Yao</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Huang</surname><given-names>M.</given-names></name>; <name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>Q.</given-names></name>; <name><surname>Zhu</surname><given-names>T.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Mu</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Tang</surname><given-names>T.</given-names></name>; <name><surname>Ren</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Lin</surname><given-names>S.-H.</given-names></name>; <name><surname>Qiu</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>D.-Y.</given-names></name>; <name><surname>Shang</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>X.</given-names></name>
<article-title>Plasma Metabolomic and Lipidomic Alterations Associated
with COVID-19</article-title>. <source>Natl. Sci. Rev.</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1093/nsr/nwaa086</pub-id>.</mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name><surname>Ghaffari</surname><given-names>S.</given-names></name>; <name><surname>Roshanravan</surname><given-names>N.</given-names></name>; <name><surname>Tutunchi</surname><given-names>H.</given-names></name>; <name><surname>Ostadrahimi</surname><given-names>A.</given-names></name>; <name><surname>Pouraghaei</surname><given-names>M.</given-names></name>; <name><surname>Kafil</surname><given-names>B.</given-names></name>
<article-title>Oleoylethanolamide, A Bioactive Lipid Amide, as A
Promising Treatment Strategy for
Coronavirus/COVID-19</article-title>. <source>Arch. Med. Res.</source>
<year>2020</year>, <volume>51</volume>, <fpage>464</fpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2020.04.006</pub-id>.<pub-id pub-id-type="pmid">32327293</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name><surname>Das</surname><given-names>U. N.</given-names></name>
<article-title>Can Bioactive Lipids Inactivate Coronavirus
(COVID-19)?</article-title>. <source>Arch. Med. Res.</source>
<year>2020</year>, <volume>51</volume>, <fpage>282</fpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2020.03.004</pub-id>.<pub-id pub-id-type="pmid">32229155</pub-id></mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name><surname>Tam</surname><given-names>V. C.</given-names></name>; <name><surname>Quehenberger</surname><given-names>O.</given-names></name>; <name><surname>Oshansky</surname><given-names>C. M.</given-names></name>; <name><surname>Suen</surname><given-names>R.</given-names></name>; <name><surname>Armando</surname><given-names>A. M.</given-names></name>; <name><surname>Treuting</surname><given-names>P. M.</given-names></name>; <name><surname>Thomas</surname><given-names>P. G.</given-names></name>; <name><surname>Dennis</surname><given-names>E. A.</given-names></name>; <name><surname>Aderem</surname><given-names>A.</given-names></name>
<article-title>Lipidomic Profiling of Influenza Infection Identifies
Mediators That Induce and Resolve Inflammation</article-title>. <source>Cell</source>
<year>2013</year>, <volume>154</volume> (<issue>1</issue>), <fpage>213</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.05.052</pub-id>.<pub-id pub-id-type="pmid">23827684</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name><surname>Sahu</surname><given-names>S.</given-names></name>; <name><surname>Lynn</surname><given-names>W. S.</given-names></name>
<article-title>Lipid Composition of Sputum from Patients with Asthma
and Patients with Cystic Fibrosis</article-title>. <source>Inflammation</source>
<year>1978</year>, <volume>3</volume> (<issue>1</issue>), <fpage>27</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/BF00917319</pub-id>.<pub-id pub-id-type="pmid">581080</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="weblink" id="cit81"><article-title>Metabolomic
profiling of regulatory lipid mediators in sputum from adult
cystic fibrosis patients | Elsevier Enhanced
Reader</article-title>. <year>2020</year>,
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.05.001</pub-id> (accessed
2020-05-18).</mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name><surname>Wei</surname><given-names>X.</given-names></name>; <name><surname>Zeng</surname><given-names>W.</given-names></name>; <name><surname>Su</surname><given-names>J.</given-names></name>; <name><surname>Wan</surname><given-names>H.</given-names></name>; <name><surname>Yu</surname><given-names>X.</given-names></name>; <name><surname>Cao</surname><given-names>X.</given-names></name>; <name><surname>Tan</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>
<article-title>Hypolipidemia Is Associated with the Severity of
COVID-19</article-title>. <source>J. Clin. Lipidol.</source>
<year>2020</year>, <volume>14</volume>, <fpage>297</fpage><pub-id pub-id-type="doi">10.1016/j.jacl.2020.04.008</pub-id>.<pub-id pub-id-type="pmid">32430154</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name><surname>Patti</surname><given-names>G. J.</given-names></name>; <name><surname>Yanes</surname><given-names>O.</given-names></name>; <name><surname>Siuzdak</surname><given-names>G.</given-names></name>
<article-title>Metabolomics: The Apogee of the Omics
Trilogy</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source>
<year>2012</year>, <volume>13</volume> (<issue>4</issue>), <fpage>263</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3314</pub-id>.<pub-id pub-id-type="pmid">22436749</pub-id></mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name><surname>Wishart</surname><given-names>D. S.</given-names></name>
<article-title>Emerging Applications of Metabolomics in Drug Discovery
and Precision Medicine</article-title>. <source>Nat. Rev. Drug Discovery</source>
<year>2016</year>, <volume>15</volume> (<issue>7</issue>), <fpage>473</fpage>&#x02013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2016.32</pub-id>.<pub-id pub-id-type="pmid">26965202</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name><surname>Hao</surname><given-names>J.</given-names></name>; <name><surname>Liebeke</surname><given-names>M.</given-names></name>; <name><surname>Astle</surname><given-names>W.</given-names></name>; <name><surname>De Iorio</surname><given-names>M.</given-names></name>; <name><surname>Bundy</surname><given-names>J. G.</given-names></name>; <name><surname>Ebbels</surname><given-names>T. M. D.</given-names></name>
<article-title>Bayesian Deconvolution and Quantification of
Metabolites in Complex 1D NMR Spectra Using
BATMAN</article-title>. <source>Nat. Protoc.</source>
<year>2014</year>, <volume>9</volume> (<issue>6</issue>), <fpage>1416</fpage>&#x02013;<lpage>1427</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2014.090</pub-id>.<pub-id pub-id-type="pmid">24853927</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Kabir</surname><given-names>M.</given-names></name>; <name><surname>Haque</surname><given-names>R.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>
<article-title>Decoding the Metabolome and Lipidome of Child
Malnutrition by Mass Spectrometric Techniques: Present Status
and Future Perspectives</article-title>. <source>Anal. Chem.</source>
<year>2019</year>, <volume>91</volume> (<issue>23</issue>), <fpage>14784</fpage>&#x02013;<lpage>14791</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.9b03338</pub-id>.<pub-id pub-id-type="pmid">31682425</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal" id="cit87"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Sternberg</surname><given-names>S.</given-names></name>; <name><surname>Williams</surname><given-names>M.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>
<article-title>Comparison of Global Metabolite Extraction Strategies
for Soybeans Using UHPLC-HRMS</article-title>. <source>Anal. Bioanal. Chem.</source>
<year>2017</year>, <volume>409</volume> (<issue>26</issue>), <fpage>6173</fpage>&#x02013;<lpage>6180</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-017-0557-6</pub-id>.<pub-id pub-id-type="pmid">28844081</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name><surname>Lee</surname><given-names>B.</given-names></name>; <name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Marchica</surname><given-names>J.</given-names></name>; <name><surname>Derezi&#x00144;ski</surname><given-names>P.</given-names></name>; <name><surname>Qi</surname><given-names>F.</given-names></name>; <name><surname>Wang</surname><given-names>F.</given-names></name>; <name><surname>Joshi</surname><given-names>P.</given-names></name>; <name><surname>Valerio</surname><given-names>F.</given-names></name>; <name><surname>Rivera</surname><given-names>I.</given-names></name>; <name><surname>Patel</surname><given-names>V.</given-names></name>; <name><surname>Pavlovich</surname><given-names>C. P.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Schroth</surname><given-names>G. P.</given-names></name>; <name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Perera</surname><given-names>R. J.</given-names></name>
<article-title>Integrated RNA and Metabolite Profiling of Urine Liquid
Biopsies for Prostate Cancer Biomarker Discovery</article-title>. <source>Sci. Rep.</source>
<year>2020</year>, <volume>10</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-60616-z</pub-id>.<pub-id pub-id-type="pmid">31913322</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name><surname>Nelson</surname><given-names>E. R.</given-names></name>; <name><surname>Wardell</surname><given-names>S. E.</given-names></name>; <name><surname>Jasper</surname><given-names>J. S.</given-names></name>; <name><surname>Park</surname><given-names>S.</given-names></name>; <name><surname>Suchindran</surname><given-names>S.</given-names></name>; <name><surname>Howe</surname><given-names>M. K.</given-names></name>; <name><surname>Carver</surname><given-names>N. J.</given-names></name>; <name><surname>Pillai</surname><given-names>R. V.</given-names></name>; <name><surname>Sullivan</surname><given-names>P. M.</given-names></name>; <name><surname>Sondhi</surname><given-names>V.</given-names></name>; <name><surname>Umetani</surname><given-names>M.</given-names></name>; <name><surname>Geradts</surname><given-names>J.</given-names></name>; <name><surname>McDonnell</surname><given-names>D. P.</given-names></name>
<article-title>27-Hydroxycholesterol Links Hypercholesterolemia and
Breast Cancer Pathophysiology</article-title>. <source>Science</source>
<year>2013</year>, <volume>342</volume> (<issue>6162</issue>), <fpage>1094</fpage>&#x02013;<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1126/science.1241908</pub-id>.<pub-id pub-id-type="pmid">24288332</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name><surname>Mayers</surname><given-names>J. R.</given-names></name>; <name><surname>Wu</surname><given-names>C.</given-names></name>; <name><surname>Clish</surname><given-names>C. B.</given-names></name>; <name><surname>Kraft</surname><given-names>P.</given-names></name>; <name><surname>Torrence</surname><given-names>M. E.</given-names></name>; <name><surname>Fiske</surname><given-names>B. P.</given-names></name>; <name><surname>Yuan</surname><given-names>C.</given-names></name>; <name><surname>Bao</surname><given-names>Y.</given-names></name>; <name><surname>Townsend</surname><given-names>M. K.</given-names></name>; <name><surname>Tworoger</surname><given-names>S. S.</given-names></name>; <name><surname>Davidson</surname><given-names>S. M.</given-names></name>; <name><surname>Papagiannakopoulos</surname><given-names>T.</given-names></name>; <name><surname>Yang</surname><given-names>A.</given-names></name>; <name><surname>Dayton</surname><given-names>T. L.</given-names></name>; <name><surname>Ogino</surname><given-names>S.</given-names></name>; <name><surname>Stampfer</surname><given-names>M. J.</given-names></name>; <name><surname>Giovannucci</surname><given-names>E. L.</given-names></name>; <name><surname>Qian</surname><given-names>Z. R.</given-names></name>; <name><surname>Rubinson</surname><given-names>D. A.</given-names></name>; <name><surname>Ma</surname><given-names>J.</given-names></name>; <name><surname>Sesso</surname><given-names>H. D.</given-names></name>; <name><surname>Gaziano</surname><given-names>J. M.</given-names></name>; <name><surname>Cochrane</surname><given-names>B. B.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Wactawski-Wende</surname><given-names>J.</given-names></name>; <name><surname>Manson</surname><given-names>J. E.</given-names></name>; <name><surname>Pollak</surname><given-names>M. N.</given-names></name>; <name><surname>Kimmelman</surname><given-names>A. C.</given-names></name>; <name><surname>Souza</surname><given-names>A.</given-names></name>; <name><surname>Pierce</surname><given-names>K.</given-names></name>; <name><surname>Wang</surname><given-names>T. J.</given-names></name>; <name><surname>Gerszten</surname><given-names>R. E.</given-names></name>; <name><surname>Fuchs</surname><given-names>C. S.</given-names></name>; <name><surname>Vander Heiden</surname><given-names>M. G.</given-names></name>; <name><surname>Wolpin</surname><given-names>B. M.</given-names></name>
<article-title>Elevation of Circulating Branched-Chain Amino Acids Is
an Early Event in Human Pancreatic Adenocarcinoma
Development</article-title>. <source>Nat. Med.</source>
<year>2014</year>, <volume>20</volume> (<issue>10</issue>), <fpage>1193</fpage>&#x02013;<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3686</pub-id>.<pub-id pub-id-type="pmid">25261994</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name><surname>Menzies</surname><given-names>V.</given-names></name>; <name><surname>Starkweather</surname><given-names>A.</given-names></name>; <name><surname>Yao</surname><given-names>Y.</given-names></name>; <name><surname>Kelly</surname><given-names>D. L.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Yang</surname><given-names>G.</given-names></name>; <name><surname>Booker</surname><given-names>S.</given-names></name>; <name><surname>Swift-Scanlan</surname><given-names>T.</given-names></name>; <name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Lyon</surname><given-names>D. E.</given-names></name>
<article-title>Exploring Associations Between Metabolites and Symptoms
of Fatigue, Depression and Pain in Women With
Fibromyalgia:</article-title>. <source>Biol. Res. Nurs.</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1177/1099800420941109</pub-id>.</mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name><surname>Lynch Kelly</surname><given-names>D.</given-names></name>; <name><surname>Farhadfar</surname><given-names>N.</given-names></name>; <name><surname>Starkweather</surname><given-names>A.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J</given-names></name>; <name><surname>Yao</surname><given-names>Y.</given-names></name>; <name><surname>Wingard</surname><given-names>J. R.</given-names></name>; <name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Menzies</surname><given-names>V.</given-names></name>; <name><surname>Patel</surname><given-names>P.</given-names></name>; <name><surname>Alabasi</surname><given-names>K. M.</given-names></name>; <name><surname>Lyon</surname><given-names>D.</given-names></name>
<article-title>Global Metabolomics in Allogeneic Hematopoietic Cell
Transplantation Recipients Discordant for Chronic
Graft-versus-Host Disease</article-title>. <source>Biol. Blood Marrow Transplant.</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1016/j.bbmt.2020.06.014</pub-id>.</mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name><surname>Fu</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Dong</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Jiang</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Shui</surname><given-names>W.</given-names></name>
<article-title>Novel Chemical Ligands to Ebola Virus and Marburg Virus
Nucleoproteins Identified by Combining Affinity Mass
Spectrometry and Metabolomics Approaches</article-title>. <source>Sci. Rep.</source>
<year>2016</year>, <volume>6</volume>, <fpage>29680</fpage><pub-id pub-id-type="doi">10.1038/srep29680</pub-id>.<pub-id pub-id-type="pmid">27403722</pub-id></mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name><surname>Tian</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>K.</given-names></name>; <name><surname>Min</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Cao</surname><given-names>Y.</given-names></name>; <name><surname>Ding</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>
<article-title>Metabolomic Analysis of Influenza A Virus A/WSN/1933
(H1N1) Infected A549 Cells during First Cycle of Viral
Replication</article-title>. <source>Viruses</source>
<year>2019</year>, <volume>11</volume> (<issue>11</issue>), <fpage>1007</fpage><pub-id pub-id-type="doi">10.3390/v11111007</pub-id>.</mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name><surname>Wu</surname><given-names>D.</given-names></name>; <name><surname>Shu</surname><given-names>T.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Song</surname><given-names>J.-X.</given-names></name>; <name><surname>Zhang</surname><given-names>M.</given-names></name>; <name><surname>Yao</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Huang</surname><given-names>M.</given-names></name>; <name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>Q.</given-names></name>; <name><surname>Zhu</surname><given-names>T.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Mu</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Tang</surname><given-names>T.</given-names></name>; <name><surname>Ren</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Lin</surname><given-names>S.-H.</given-names></name>; <name><surname>Qiu</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>D.-Y.</given-names></name>; <name><surname>Shang</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>X.</given-names></name>
<article-title>Plasma Metabolomic and Lipidomic Alterations Associated
with COVID-19</article-title>. <source>Natl. Sci. Rev.</source>
<year>2020</year>, <volume>7</volume>, <fpage>1157</fpage><pub-id pub-id-type="doi">10.1093/nsr/nwaa086</pub-id>.</mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name><surname>Bogan</surname><given-names>K. L.</given-names></name>; <name><surname>Brenner</surname><given-names>C.</given-names></name>
<article-title>Nicotinic Acid, Nicotinamide, and Nicotinamide
Riboside: A Molecular Evaluation of NAD+ Precursor Vitamins in
Human Nutrition</article-title>. <source>Annu. Rev. Nutr.</source>
<year>2008</year>, <volume>28</volume>, <fpage>115</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.nutr.28.061807.155443</pub-id>.<pub-id pub-id-type="pmid">18429699</pub-id></mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal" id="cit97"><name><surname>Blanco-Melo</surname><given-names>D.</given-names></name>; <name><surname>Nilsson-Payant</surname><given-names>B. E.</given-names></name>; <name><surname>Liu</surname><given-names>W.-C.</given-names></name>; <name><surname>M&#x000f8;ller</surname><given-names>R.</given-names></name>; <name><surname>Panis</surname><given-names>M.</given-names></name>; <name><surname>Sachs</surname><given-names>D.</given-names></name>; <name><surname>Albrecht</surname><given-names>R. A.</given-names></name>; <name><surname>Tenoever</surname><given-names>B. R.</given-names></name>
<article-title>SARS-CoV-2 Launches a Unique Transcriptional Signature
from in Vitro, Ex Vivo, and in Vivo Systems</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.03.24.004655</pub-id>.</mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal" id="cit98"><name><surname>Heer</surname><given-names>C. D.</given-names></name>; <name><surname>Sanderson</surname><given-names>D. J.</given-names></name>; <name><surname>Alhammad</surname><given-names>Y. M. O.</given-names></name>; <name><surname>Schmidt</surname><given-names>M. S.</given-names></name>; <name><surname>Trammell</surname><given-names>S. A. J.</given-names></name>; <name><surname>Perlman</surname><given-names>S.</given-names></name>; <name><surname>Cohen</surname><given-names>M. S.</given-names></name>; <name><surname>Fehr</surname><given-names>A. R.</given-names></name>; <name><surname>Brenner</surname><given-names>C.</given-names></name>
<article-title>Coronavirus Infection and PARP Expression Dysregulate
the NAD Metabolome: A Potentially Actionable Component of Innate
Immunity</article-title>. <source>bioRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1101/2020.04.17.047480</pub-id>.</mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name><surname>Zhu</surname><given-names>N.</given-names></name>; <name><surname>Zhang</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>B.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name>; <name><surname>Zhao</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>B.</given-names></name>; <name><surname>Shi</surname><given-names>W.</given-names></name>; <name><surname>Lu</surname><given-names>R.</given-names></name>; <name><surname>Niu</surname><given-names>P.</given-names></name>; <name><surname>Zhan</surname><given-names>F.</given-names></name>; <name><surname>Ma</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>Wu</surname><given-names>G.</given-names></name>; <name><surname>Gao</surname><given-names>G. F.</given-names></name>; <name><surname>Tan</surname><given-names>W.</given-names></name>
<article-title>A Novel Coronavirus from Patients with Pneumonia in
China, 2019</article-title>. <source>N. Engl. J. Med.</source>
<year>2020</year>, <volume>382</volume> (<issue>8</issue>), <fpage>727</fpage>&#x02013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id>.<pub-id pub-id-type="pmid">31978945</pub-id></mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal" id="cit100"><name><surname>Zou</surname><given-names>L.</given-names></name>; <name><surname>Ruan</surname><given-names>F.</given-names></name>; <name><surname>Huang</surname><given-names>M.</given-names></name>; <name><surname>Liang</surname><given-names>L.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Hong</surname><given-names>Z.</given-names></name>; <name><surname>Yu</surname><given-names>J.</given-names></name>; <name><surname>Kang</surname><given-names>M.</given-names></name>; <name><surname>Song</surname><given-names>Y.</given-names></name>; <name><surname>Xia</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>Q.</given-names></name>; <name><surname>Song</surname><given-names>T.</given-names></name>; <name><surname>He</surname><given-names>J.</given-names></name>; <name><surname>Yen</surname><given-names>H.-L.</given-names></name>; <name><surname>Peiris</surname><given-names>M.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>
<article-title>SARS-CoV-2 Viral Load in Upper Respiratory Specimens of
Infected Patients</article-title>. <source>N. Engl. J. Med.</source>
<year>2020</year>, <volume>382</volume> (<issue>12</issue>), <fpage>1177</fpage>&#x02013;<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2001737</pub-id>.<pub-id pub-id-type="pmid">32074444</pub-id></mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal" id="cit101"><name><surname>Khoubnasabjafari</surname><given-names>M.</given-names></name>; <name><surname>Jouyban-Gharamaleki</surname><given-names>V.</given-names></name>; <name><surname>Ghanbari</surname><given-names>R.</given-names></name>; <name><surname>Jouyban</surname><given-names>A.</given-names></name>
<article-title>Exhaled Breath Condensate as a Potential Specimen for
Diagnosing COVID-19</article-title>. <source>Bioanalysis</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.4155/bio-2020-0083</pub-id>.</mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal" id="cit102"><name><surname>Tang</surname><given-names>Y.-W.</given-names></name>; <name><surname>Schmitz</surname><given-names>J. E.</given-names></name>; <name><surname>Persing</surname><given-names>D. H.</given-names></name>; <name><surname>Stratton</surname><given-names>C. W.</given-names></name>
<article-title>Laboratory Diagnosis of COVID-19: Current Issues and
Challenges</article-title>. <source>J. Clin. Microbiol.</source>
<year>2020</year>, <volume>58</volume> (<issue>6</issue>), <elocation-id>e00512</elocation-id><pub-id pub-id-type="doi">10.1128/JCM.00512-20</pub-id>.<pub-id pub-id-type="pmid">32245835</pub-id></mixed-citation></ref><ref id="ref103"><mixed-citation publication-type="journal" id="cit103"><name><surname>Darnell</surname><given-names>M. E. R.</given-names></name>; <name><surname>Subbarao</surname><given-names>K.</given-names></name>; <name><surname>Feinstone</surname><given-names>S. M.</given-names></name>; <name><surname>Taylor</surname><given-names>D. R.</given-names></name>
<article-title>Inactivation of the Coronavirus That Induces Severe
Acute Respiratory Syndrome, SARS-CoV</article-title>. <source>J. Virol. Methods</source>
<year>2004</year>, <volume>121</volume> (<issue>1</issue>), <fpage>85</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2004.06.006</pub-id>.<pub-id pub-id-type="pmid">15350737</pub-id></mixed-citation></ref><ref id="ref104"><mixed-citation publication-type="journal" id="cit104"><name><surname>Wolk</surname><given-names>D. M.</given-names></name>; <name><surname>Kaleta</surname><given-names>E. J.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>
<article-title>PCR-Electrospray Ionization Mass Spectrometry: The
Potential to Change Infectious Disease Diagnostics in Clinical
and Public Health Laboratories</article-title>. <source>J. Mol. Diagn.</source>
<year>2012</year>, <volume>14</volume> (<issue>4</issue>), <fpage>295</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmoldx.2012.02.005</pub-id>.<pub-id pub-id-type="pmid">22584138</pub-id></mixed-citation></ref><ref id="ref105"><mixed-citation publication-type="journal" id="cit105"><name><surname>Pinto</surname><given-names>F. G.</given-names></name>; <name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Harmon</surname><given-names>T. A.</given-names></name>; <name><surname>Rubio</surname><given-names>V. Y.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>
<article-title>Rapid Prostate Cancer Noninvasive Biomarker Screening
Using Segmented Flow Mass Spectrometry-Based Untargeted
Metabolomics</article-title>. <source>J. Proteome Res.</source>
<year>2020</year>, <volume>19</volume> (<issue>5</issue>), <fpage>2080</fpage>&#x02013;<lpage>2091</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.0c00006</pub-id>.<pub-id pub-id-type="pmid">32216312</pub-id></mixed-citation></ref><ref id="ref106"><mixed-citation publication-type="journal" id="cit106"><name><surname>Chamberlain</surname><given-names>C. A.</given-names></name>; <name><surname>Rubio</surname><given-names>V. Y.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>
<article-title>Strain-Level Differentiation of Bacteria by Paper Spray
Ionization Mass Spectrometry</article-title>. <source>Anal. Chem.</source>
<year>2019</year>, <volume>91</volume> (<issue>8</issue>), <fpage>4964</fpage>&#x02013;<lpage>4968</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.9b00330</pub-id>.<pub-id pub-id-type="pmid">30888152</pub-id></mixed-citation></ref><ref id="ref107"><mixed-citation publication-type="journal" id="cit107"><name><surname>Thomas</surname><given-names>J. J.</given-names></name>; <name><surname>Shen</surname><given-names>Z.</given-names></name>; <name><surname>Crowell</surname><given-names>J. E.</given-names></name>; <name><surname>Finn</surname><given-names>M. G.</given-names></name>; <name><surname>Siuzdak</surname><given-names>G.</given-names></name>
<article-title>Desorption/Ionization on Silicon (DIOS): A Diverse Mass
Spectrometry Platform for Protein
Characterization</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2001</year>, <volume>98</volume> (<issue>9</issue>), <fpage>4932</fpage>&#x02013;<lpage>4937</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.081069298</pub-id>.<pub-id pub-id-type="pmid">11296246</pub-id></mixed-citation></ref><ref id="ref108"><mixed-citation publication-type="journal" id="cit108"><name><surname>Baluya</surname><given-names>D. L.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Yost</surname><given-names>R. A.</given-names></name>
<article-title>Automated MALDI Matrix Deposition Method with Inkjet
Printing for Imaging Mass Spectrometry</article-title>. <source>Anal. Chem.</source>
<year>2007</year>, <volume>79</volume> (<issue>17</issue>), <fpage>6862</fpage>&#x02013;<lpage>6867</lpage>. <pub-id pub-id-type="doi">10.1021/ac070958d</pub-id>.<pub-id pub-id-type="pmid">17658766</pub-id></mixed-citation></ref><ref id="ref109"><mixed-citation publication-type="journal" id="cit109"><name><surname>Drexler</surname><given-names>D. M.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Cantone</surname><given-names>J. L.</given-names></name>; <name><surname>Diters</surname><given-names>R. W.</given-names></name>; <name><surname>Mitroka</surname><given-names>J. G.</given-names></name>; <name><surname>Prieto Conaway</surname><given-names>M. C.</given-names></name>; <name><surname>Adams</surname><given-names>S. P.</given-names></name>; <name><surname>Yost</surname><given-names>R. A.</given-names></name>; <name><surname>Sanders</surname><given-names>M.</given-names></name>
<article-title>Utility of Imaging Mass Spectrometry (IMS) by
Matrix-Assisted Laser Desorption Ionization (MALDI) on an Ion
Trap Mass Spectrometer in the Analysis of Drugs and Metabolites
in Biological Tissues</article-title>. <source>J. Pharmacol. Toxicol. Methods</source>
<year>2007</year>, <volume>55</volume> (<issue>3</issue>), <fpage>279</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.vascn.2006.11.004</pub-id>.<pub-id pub-id-type="pmid">17222568</pub-id></mixed-citation></ref><ref id="ref110"><mixed-citation publication-type="journal" id="cit110"><name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Dawson</surname><given-names>W. W.</given-names></name>
<article-title>Lipid Geographical Analysis of the Primate Macula by
Imaging Mass Spectrometry</article-title>. <source>Methods Mol. Biol.</source>
<year>2009</year>, <volume>579</volume>, <fpage>247</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-322-0_12</pub-id>.<pub-id pub-id-type="pmid">19763479</pub-id></mixed-citation></ref><ref id="ref111"><mixed-citation publication-type="journal" id="cit111"><name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Menger</surname><given-names>R. F.</given-names></name>; <name><surname>Dawson</surname><given-names>W. W.</given-names></name>; <name><surname>Yost</surname><given-names>R. A.</given-names></name>
<article-title>Lipid Analysis of Flat-Mounted Eye Tissue by Imaging
Mass Spectrometry with Identification of Contaminants in
Preservation</article-title>. <source>Anal. Bioanal. Chem.</source>
<year>2011</year>, <volume>401</volume> (<issue>1</issue>), <fpage>103</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-011-5044-x</pub-id>.<pub-id pub-id-type="pmid">21556752</pub-id></mixed-citation></ref><ref id="ref112"><mixed-citation publication-type="journal" id="cit112"><name><surname>Landgraf</surname><given-names>R. R.</given-names></name>; <name><surname>Prieto Conaway</surname><given-names>M. C.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Stacpoole</surname><given-names>P. W.</given-names></name>; <name><surname>Yost</surname><given-names>R. A.</given-names></name>
<article-title>Imaging of Lipids in Spinal Cord Using Intermediate
Pressure Matrix-Assisted Laser Desorption-Linear Ion
Trap/Orbitrap MS</article-title>. <source>Anal. Chem.</source>
<year>2009</year>, <volume>81</volume> (<issue>20</issue>), <fpage>8488</fpage>&#x02013;<lpage>8495</lpage>. <pub-id pub-id-type="doi">10.1021/ac901387u</pub-id>.<pub-id pub-id-type="pmid">19751051</pub-id></mixed-citation></ref><ref id="ref113"><mixed-citation publication-type="journal" id="cit113"><name><surname>Drexler</surname><given-names>D. M.</given-names></name>; <name><surname>Garrett</surname><given-names>T. J.</given-names></name>; <name><surname>Cantone</surname><given-names>J. L.</given-names></name>; <name><surname>Diters</surname><given-names>R. W.</given-names></name>; <name><surname>Mitroka</surname><given-names>J. G.</given-names></name>; <name><surname>Prieto Conaway</surname><given-names>M. C.</given-names></name>; <name><surname>Adams</surname><given-names>S. P.</given-names></name>; <name><surname>Yost</surname><given-names>R. A.</given-names></name>; <name><surname>Sanders</surname><given-names>M.</given-names></name>
<article-title>Utility of Imaging Mass Spectrometry (IMS) by
Matrix-Assisted Laser Desorption Ionization (MALDI) on an Ion
Trap Mass Spectrometer in the Analysis of Drugs and Metabolites
in Biological Tissues</article-title>. <source>J. Pharmacol. Toxicol. Methods</source>
<year>2007</year>, <volume>55</volume> (<issue>3</issue>), <fpage>279</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.vascn.2006.11.004</pub-id>.<pub-id pub-id-type="pmid">17222568</pub-id></mixed-citation></ref><ref id="ref114"><mixed-citation publication-type="journal" id="cit114"><name><surname>Buchan</surname><given-names>B. W.</given-names></name>; <name><surname>Ledeboer</surname><given-names>N. A.</given-names></name>
<article-title>Emerging Technologies for the Clinical Microbiology
Laboratory</article-title>. <source>Clin. Microbiol. Rev.</source>
<year>2014</year>, <volume>27</volume> (<issue>4</issue>), <fpage>783</fpage>&#x02013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00003-14</pub-id>.<pub-id pub-id-type="pmid">25278575</pub-id></mixed-citation></ref><ref id="ref115"><mixed-citation publication-type="journal" id="cit115"><name><surname>Snyder</surname><given-names>D. T.</given-names></name>; <name><surname>Pulliam</surname><given-names>C. J.</given-names></name>; <name><surname>Ouyang</surname><given-names>Z.</given-names></name>; <name><surname>Cooks</surname><given-names>R. G.</given-names></name>
<article-title>Miniature and Fieldable Mass Spectrometers: Recent
Advances</article-title>. <source>Anal. Chem.</source>
<year>2016</year>, <volume>88</volume> (<issue>1</issue>), <fpage>2</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.5b03070</pub-id>.<pub-id pub-id-type="pmid">26422665</pub-id></mixed-citation></ref><ref id="ref116"><mixed-citation publication-type="journal" id="cit116"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Kousik</surname><given-names>C.</given-names></name>; <name><surname>Hassell</surname><given-names>R.</given-names></name>; <name><surname>Chowdhury</surname><given-names>K.</given-names></name>; <name><surname>Boroujerdi</surname><given-names>A. F.</given-names></name>
<article-title>NMR Spectroscopy Identifies Metabolites Translocated
from Powdery Mildew Resistant Rootstocks to Susceptible
Watermelon Scions</article-title>. <source>J. Agric. Food Chem.</source>
<year>2015</year>, <volume>63</volume> (<issue>36</issue>), <fpage>8083</fpage>&#x02013;<lpage>8091</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.5b02108</pub-id>.<pub-id pub-id-type="pmid">26302171</pub-id></mixed-citation></ref><ref id="ref117"><mixed-citation publication-type="journal" id="cit117"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Thapaliya</surname><given-names>M.</given-names></name>; <name><surname>Boroujerdi</surname><given-names>A.</given-names></name>; <name><surname>Chowdhury</surname><given-names>K.</given-names></name>
<article-title>NMR-Based Metabolomics Study of the Biochemical
Relationship between Sugarcane Callus Tissues and Their
Respective Nutrient Culture Media</article-title>. <source>Anal. Bioanal. Chem.</source>
<year>2014</year>, <volume>406</volume> (<issue>24</issue>), <fpage>5997</fpage>&#x02013;<lpage>6005</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-014-8002-6</pub-id>.<pub-id pub-id-type="pmid">25012359</pub-id></mixed-citation></ref><ref id="ref118"><mixed-citation publication-type="journal" id="cit118"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Shrestha</surname><given-names>B.</given-names></name>; <name><surname>Boroujerdi</surname><given-names>A.</given-names></name>; <name><surname>Chowdhury</surname><given-names>K.</given-names></name>
<article-title>NMR-Based Metabolomics Profile Comparisons to
Distinguish between Embryogenic and Non-Embryogenic Callus
Tissue of Sugarcane at the Biochemical Level</article-title>. <source>In Vitro Cell. Dev. Biol.: Plant</source>
<year>2015</year>, <volume>51</volume> (<issue>3</issue>), <fpage>340</fpage>&#x02013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1007/s11627-015-9687-8</pub-id>.</mixed-citation></ref><ref id="ref119"><mixed-citation publication-type="journal" id="cit119"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Chowdhury</surname><given-names>K.</given-names></name>; <name><surname>Boroujerdi</surname><given-names>A.</given-names></name>
<article-title>Tissue-Specific Metabolic Profile Study of Moringa
Oleifera L. Using Nuclear Magnetic Resonance
Spectroscopy</article-title>. <source>Plant Tissue Cult. Biotechnol. Bangladesh Assoc. Plant Tissue
Cult. Biotechnol. BAPTCB</source>
<year>2014</year>, <volume>24</volume> (<issue>1</issue>), <fpage>77</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.3329/ptcb.v24i1.19214</pub-id>.</mixed-citation></ref><ref id="ref120"><mixed-citation publication-type="journal" id="cit120"><name><surname>Hatzakis</surname><given-names>E.</given-names></name>
<article-title>Nuclear Magnetic Resonance (NMR) Spectroscopy in Food
Science: A Comprehensive Review</article-title>. <source>Compr. Rev. Food Sci. Food Saf.</source>
<year>2019</year>, <volume>18</volume> (<issue>1</issue>), <fpage>189</fpage>&#x02013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1111/1541-4337.12408</pub-id>.</mixed-citation></ref><ref id="ref121"><mixed-citation publication-type="journal" id="cit121"><name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Drabek</surname><given-names>D.</given-names></name>; <name><surname>Okba</surname><given-names>N. M. A.</given-names></name>; <name><surname>van Haperen</surname><given-names>R.</given-names></name>; <name><surname>Osterhaus</surname><given-names>A. D. M. E.</given-names></name>; <name><surname>van Kuppeveld</surname><given-names>F. J. M.</given-names></name>; <name><surname>Haagmans</surname><given-names>B. L.</given-names></name>; <name><surname>Grosveld</surname><given-names>F.</given-names></name>; <name><surname>Bosch</surname><given-names>B.-J.</given-names></name>
<article-title>A Human Monoclonal Antibody Blocking SARS-CoV-2
Infection</article-title>. <source>Nat. Commun.</source>
<year>2020</year>, <volume>11</volume> (<issue>1</issue>), <fpage>2251</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-16256-y</pub-id>.<pub-id pub-id-type="pmid">32366817</pub-id></mixed-citation></ref><ref id="ref122"><mixed-citation publication-type="journal" id="cit122"><name><surname>Srzenti&#x00107;</surname><given-names>K.</given-names></name>; <name><surname>Fornelli</surname><given-names>L.</given-names></name>; <name><surname>Tsybin</surname><given-names>Y. O.</given-names></name>; <name><surname>Loo</surname><given-names>J. A.</given-names></name>; <name><surname>Seckler</surname><given-names>H.</given-names></name>; <name><surname>Agar</surname><given-names>J. N.</given-names></name>; <name><surname>Anderson</surname><given-names>L. C.</given-names></name>; <name><surname>Bai</surname><given-names>D. L.</given-names></name>; <name><surname>Beck</surname><given-names>A.</given-names></name>; <name><surname>Brodbelt</surname><given-names>J. S.</given-names></name>; <name><surname>van der Burgt</surname><given-names>Y. E. M.</given-names></name>; <name><surname>Chamot-Rooke</surname><given-names>J.</given-names></name>; <name><surname>Chatterjee</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Clarke</surname><given-names>D. J.</given-names></name>; <name><surname>Danis</surname><given-names>P. O.</given-names></name>; <name><surname>Diedrich</surname><given-names>J. K.</given-names></name>; <name><surname>D&#x02019;Ippolito</surname><given-names>R. A.</given-names></name>; <name><surname>Dupr&#x000e9;</surname><given-names>M.</given-names></name>; <name><surname>Gasilova</surname><given-names>N.</given-names></name>; <name><surname>Ge</surname><given-names>Y.</given-names></name>; <name><surname>Goo</surname><given-names>Y. A.</given-names></name>; <name><surname>Goodlett</surname><given-names>D. R.</given-names></name>; <name><surname>Greer</surname><given-names>S.</given-names></name>; <name><surname>Haselmann</surname><given-names>K. F.</given-names></name>; <name><surname>He</surname><given-names>L.</given-names></name>; <name><surname>Hendrickson</surname><given-names>C. L.</given-names></name>; <name><surname>Hinkle</surname><given-names>J. D.</given-names></name>; <name><surname>Holt</surname><given-names>M. V.</given-names></name>; <name><surname>Hughes</surname><given-names>S.</given-names></name>; <name><surname>Hunt</surname><given-names>D. F.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>; <name><surname>Kozhinov</surname><given-names>A. N.</given-names></name>; <name><surname>Lin</surname><given-names>Z.</given-names></name>; <name><surname>Malosse</surname><given-names>C.</given-names></name>; <name><surname>Marshall</surname><given-names>A. G.</given-names></name>; <name><surname>Menin</surname><given-names>L.</given-names></name>; <name><surname>Millikin</surname><given-names>R. J.</given-names></name>; <name><surname>Nagornov</surname><given-names>K. O.</given-names></name>; <name><surname>Nicolardi</surname><given-names>S.</given-names></name>; <name><surname>Pa&#x00161;a-Toli&#x00107;</surname><given-names>L.</given-names></name>; <name><surname>Pengelley</surname><given-names>S.</given-names></name>; <name><surname>Quebbemann</surname><given-names>N. R.</given-names></name>; <name><surname>Resemann</surname><given-names>A.</given-names></name>; <name><surname>Sandoval</surname><given-names>W.</given-names></name>; <name><surname>Sarin</surname><given-names>R.</given-names></name>; <name><surname>Schmitt</surname><given-names>N. D.</given-names></name>; <name><surname>Shabanowitz</surname><given-names>J.</given-names></name>; <name><surname>Shaw</surname><given-names>J. B.</given-names></name>; <name><surname>Shortreed</surname><given-names>M. R.</given-names></name>; <name><surname>Smith</surname><given-names>L. M.</given-names></name>; <name><surname>Sobott</surname><given-names>F.</given-names></name>; <name><surname>Suckau</surname><given-names>D.</given-names></name>; <name><surname>Toby</surname><given-names>T.</given-names></name>; <name><surname>Weisbrod</surname><given-names>C. R.</given-names></name>; <name><surname>Wildburger</surname><given-names>N. C.</given-names></name>; <name><surname>Yates</surname><given-names>J. R.</given-names></name>; <name><surname>Yoon</surname><given-names>S. H.</given-names></name>; <name><surname>Young</surname><given-names>N. L.</given-names></name>; <name><surname>Zhou</surname><given-names>M.</given-names></name>
<article-title>Interlaboratory Study for Characterizing Monoclonal
Antibodies by Top-Down and Middle-Down Mass
Spectrometry</article-title>. <source>J. Am. Soc. Mass Spectrom.</source>
<year>2020</year>, <volume>31</volume>, <fpage>1783</fpage><pub-id pub-id-type="doi">10.1021/jasms.0c00036</pub-id>.<pub-id pub-id-type="pmid">32812765</pub-id></mixed-citation></ref><ref id="ref123"><mixed-citation publication-type="journal" id="cit123"><name><surname>Migaud</surname><given-names>M.</given-names></name>; <name><surname>Gandotra</surname><given-names>S.</given-names></name>; <name><surname>Chand</surname><given-names>H. S.</given-names></name>; <name><surname>Gillespie</surname><given-names>M. N.</given-names></name>; <name><surname>Thannickal</surname><given-names>V. J.</given-names></name>; <name><surname>Langley</surname><given-names>R. J.</given-names></name>
<article-title>Metabolomics to Predict Antiviral Drug Efficacy in
COVID-19</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source>
<year>2020</year>, <volume>63</volume>, <fpage>396</fpage><pub-id pub-id-type="doi">10.1165/rcmb.2020-0206LE</pub-id>.<pub-id pub-id-type="pmid">32574504</pub-id></mixed-citation></ref><ref id="ref124"><mixed-citation publication-type="journal" id="cit124"><name><surname>Mahmud</surname><given-names>I.</given-names></name>; <name><surname>Liao</surname><given-names>D.</given-names></name>
<article-title>DAXX in Cancer: Phenomena, Processes, Mechanisms and
Regulation</article-title>. <source>Nucleic Acids Res.</source>
<year>2019</year>, <volume>47</volume> (<issue>15</issue>), <fpage>7734</fpage>&#x02013;<lpage>7752</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz634</pub-id>.<pub-id pub-id-type="pmid">31350900</pub-id></mixed-citation></ref><ref id="ref125"><mixed-citation publication-type="journal" id="cit125"><name><surname>Nehme</surname><given-names>Z.</given-names></name>; <name><surname>Pasquereau</surname><given-names>S.</given-names></name>; <name><surname>Herbein</surname><given-names>G.</given-names></name>
<article-title>Control of Viral Infections by Epigenetic-Targeted
Therapy</article-title>. <source>Clin. Epigenet.</source>
<year>2019</year>, <volume>11</volume> (<issue>1</issue>), <fpage>55</fpage><pub-id pub-id-type="doi">10.1186/s13148-019-0654-9</pub-id>.</mixed-citation></ref><ref id="ref126"><mixed-citation publication-type="journal" id="cit126"><name><surname>Fung</surname><given-names>T. S.</given-names></name>; <name><surname>Liu</surname><given-names>D. X.</given-names></name>
<article-title>Post-Translational Modifications of Coronavirus
Proteins: Roles and Function</article-title>. <source>Future Virol.</source>
<year>2018</year>, <volume>13</volume> (<issue>6</issue>), <fpage>405</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.2217/fvl-2018-0008</pub-id>.<pub-id pub-id-type="pmid">32201497</pub-id></mixed-citation></ref><ref id="ref127"><mixed-citation publication-type="journal" id="cit127"><name><surname>Ribet</surname><given-names>D.</given-names></name>; <name><surname>Cossart</surname><given-names>P.</given-names></name>
<article-title>Pathogen-Mediated Posttranslational Modifications: A
Re-Emerging Field</article-title>. <source>Cell</source>
<year>2010</year>, <volume>143</volume> (<issue>5</issue>), <fpage>694</fpage>&#x02013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.11.019</pub-id>.<pub-id pub-id-type="pmid">21111231</pub-id></mixed-citation></ref><ref id="ref128"><mixed-citation publication-type="journal" id="cit128"><name><surname>Rodrigues</surname><given-names>M.</given-names></name>; <name><surname>Fan</surname><given-names>J.</given-names></name>; <name><surname>Lyon</surname><given-names>C.</given-names></name>; <name><surname>Wan</surname><given-names>M.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>
<article-title>Role of Extracellular Vesicles in Viral and Bacterial
Infections: Pathogenesis, Diagnostics, and
Therapeutics</article-title>. <source>Theranostics</source>
<year>2018</year>, <volume>8</volume> (<issue>10</issue>), <fpage>2709</fpage>&#x02013;<lpage>2721</lpage>. <pub-id pub-id-type="doi">10.7150/thno.20576</pub-id>.<pub-id pub-id-type="pmid">29774070</pub-id></mixed-citation></ref><ref id="ref129"><mixed-citation publication-type="journal" id="cit129"><name><surname>Evans</surname><given-names>A. M.</given-names></name>; <name><surname>DeHaven</surname><given-names>C. D.</given-names></name>; <name><surname>Barrett</surname><given-names>T.</given-names></name>; <name><surname>Mitchell</surname><given-names>M.</given-names></name>; <name><surname>Milgram</surname><given-names>E.</given-names></name>
<article-title>Integrated, Nontargeted Ultrahigh Performance Liquid
Chromatography/Electrospray Ionization Tandem Mass Spectrometry
Platform for the Identification and Relative Quantification of
the Small-Molecule Complement of Biological
Systems</article-title>. <source>Anal. Chem.</source>
<year>2009</year>, <volume>81</volume> (<issue>16</issue>), <fpage>6656</fpage>&#x02013;<lpage>6667</lpage>. <pub-id pub-id-type="doi">10.1021/ac901536h</pub-id>.<pub-id pub-id-type="pmid">19624122</pub-id></mixed-citation></ref><ref id="ref130"><mixed-citation publication-type="journal" id="cit130"><name><surname>Thomas</surname><given-names>T.</given-names></name>; <name><surname>Stefanoni</surname><given-names>D.</given-names></name>; <name><surname>Reisz</surname><given-names>J. A.</given-names></name>; <name><surname>Nemkov</surname><given-names>T.</given-names></name>; <name><surname>Bertolone</surname><given-names>L.</given-names></name>; <name><surname>Francis</surname><given-names>R. O.</given-names></name>; <name><surname>Hudson</surname><given-names>K. E.</given-names></name>; <name><surname>Zimring</surname><given-names>J. C.</given-names></name>; <name><surname>Hansen</surname><given-names>K. C.</given-names></name>; <name><surname>Hod</surname><given-names>E. A.</given-names></name>; <name><surname>Spitalnik</surname><given-names>S. L.</given-names></name>; <name><surname>D&#x02019;Alessandro</surname><given-names>A.</given-names></name>
<article-title>COVID-19 Infection Results in Alterations of the
Kynurenine Pathway and Fatty Acid Metabolism That Correlate with
IL-6 Levels and Renal Status</article-title>. <source>medRxiv</source>
<year>2020</year>, <pub-id pub-id-type="doi">10.1172/jci.insight.140327</pub-id>.</mixed-citation></ref></ref-list></back></article>